Diet, dietary supplements and dietary change in cancer survivors and cancer-free persons :




Diet, dietary supplements and dietary change in 
cancer survivors and cancer-free persons –  
the Norwegian Women and Cancer study and 
the European Prospective Investigation into 














Institute of community medicine 





This thesis was sponsored by the Norwegian Foundation for Health and Rehabilitation via 
the Norwegian Cancer Society and the University of Tromsø. The Institute of Community 
Medicine at the University of Tromsø has been my workplace since the year 2000, and I 
thank my colleagues for a creative and stimulating work environment.  
The Norwegian Women and Cancer study group has been very interesting to work 
with. Thanks a lot to all of you! Some deserve special mention: Bente Augdal who took 
care of me when I first started in the project, and who takes care of all our questionnaires 
and blood samples. Tonje Braaten, Ilene Brill, Elin Alsaker and Marita Melhus who have 
helped me with data management, programming and statistical tips. Fellow nutritionists 
Dagrun Engeset, Magritt Brustad and Christine Parr with whom I have discussed 
methodological and other challenges, and Marit Waaseth for her knowledge on dietary 
supplements and medications. Inger Torhild Gram who has shared her experience with 
cancer research, Merete Albertsen who has taken care of much of the administrative work, 
and Kjersti Bakken and Merethe Kumle for always having open doors. 
 I also want to thank the other phd. students at the institute whom I have shared 
smaller and bigger challenges with, particularly Nina, Anne Mette, Signe and Tove.  
When I received the phd. grant, I also received a Special Training Award to go to 
the International Agency for Cancer Research in Lyon, France. I want to thank my 
colleagues there, particularly Nadia Slimani, and the rest of her group, including Carine, 
Corinne, Bertrand and Jerome. I want to thank my co-authors from the European 
Prospective Investigation into Cancer and nutrition, especially those who participated in 
the tedious work of dietary supplement reclassification. 
Two persons have been particularly important for the thesis work, Anette Hjartåker 
who constructed and validated the dietary questionnaire and has been supervising 
everything from the smallest details to the bigger lines. Eiliv Lund is the principal 
investigator of the Norwegian Women and Cancer study and has been my main supervisor. 
He gave me a job when I wanted to go to Tromsø, and he has given me challenges and 
opportunities I doubt I would have got elsewhere. I have learned a lot from both of you!  
I want to thank my family and friends for their support and patience when I have 
been one-track minded about my thesis.  
Finally, this thesis could never have been written without the more than 100 000 




List of papers ............................................................................................. 3 
Abbreviations ............................................................................................. 4 
1 Introduction ......................................................................................... 5 
1.1 Cancer survivors .............................................................................. 5 
1.1.1 Health issues for cancer survivors ...................................................... 7 
1.1.2 Dietary issues for cancer survivors ..................................................... 7 
1.2 Dietary supplement use .................................................................... 12 
1.2.1 Prevalence of dietary supplement use in cancer survivors ........................ 13 
1.2.2 Dietary supplement use, cancer incidence, survival and mortality.............. 15 
2 Aims.................................................................................................. 16 
3 Material and methods............................................................................. 17 
3.1 The Norwegian Women and Cancer study............................................... 17 
3.1.1 Sampling, invitation and ethical issues ............................................... 18 
3.1.2 Dietary assessment and validation .................................................... 21 
3.1.3 Dietary calculations...................................................................... 22 
3.1.4 Non-dietary variables.................................................................... 23 
3.1.5 Identification of cancer, vital status and emigration .............................. 24 
3.1.6 Exclusion criteria......................................................................... 24 
3.2 The European Prospective Investigation into Cancer and Nutrition ................ 27 
3.2.1 Ethical issues.............................................................................. 27 
3.2.2 Dietary assessment....................................................................... 27 
3.2.3 Non-dietary variables, exclusions and participation rates ........................ 28 
3.3 Dietary supplements........................................................................ 29 
3.4 Cancer survivors ............................................................................. 30 
3.5 Statistical analyses.......................................................................... 30 
4 Results – summary of papers..................................................................... 32 
Paper 1 .............................................................................................. 32 
Paper 2 .............................................................................................. 32 
Paper 3 .............................................................................................. 33 
Paper 4 .............................................................................................. 34 
5 Discussion ........................................................................................... 35 
5.1 Study designs ................................................................................ 35 
5.1.1 Cross-sectional versus prospective studies........................................... 35 
5.1.2 Transformed cohort studies versus dedicated survivor cohorts .................. 35 
5.1.3 24-hour dietary recalls .................................................................. 37 
5.2. Validity........................................................................................ 38 
5.2.1 Selection bias ............................................................................. 38 
5.2.2 Information bias .......................................................................... 40 
5.2.3 Statistical validity including confounding factors................................... 45 
5.2.4 External validity.......................................................................... 46 
5.3 Data interpretation ......................................................................... 46 
5.3.1 Diet in cancer survivors and cancer-free women ................................... 46 
5.3.2 Other lifestyle factors ................................................................... 49 
5.3.3 Dietary supplements..................................................................... 49 
5.3.3 Dietary supplement use and cancer survival......................................... 51 
6 Conclusions and future perspectives ........................................................... 53 
References ............................................................................................... 56 




This thesis focuses on diet and dietary change in women who have breast or colorectal 
cancer, compared to cancer-free women in the Norwegian Women and Cancer study 
(NOWAC; Kvinner og kreft). The use of dietary supplements in the European Prospective 
Investigation into Cancer and Nutrition (EPIC) is also described. Finally, the association 
between use of cod liver oil and other supplements and survival among patients with solid 
tumours from the NOWAC-study is presented.  
 Cross-sectional results from the NOWAC-study showed that the differences in diet 
among women with breast cancer (n=666) and healthy women (n=54 314) were not very 
large, but women with breast cancer ate more fruits and vegetables. Particularly women 
who had answered the questionnaire less than five years after diagnosis differed from 
healthy women. There was also a lower level of physical activity and more dietary 
supplement users among these women.  
 Change in diet among women who got colorectal (n=130) or breast cancer (n=563) 
compared to changes among cancer-free women (n=43 154) was evaluated in a follow-up 
study over almost six years. Those who got breast cancer increased fruits and vegetables 
intake more than cancer-free women did. Milk intake was unchanged among those who got 
colorectal cancer, and decreased among cancer-free women. Body mass index and alcohol 
consumption increased similarly in all groups. Smoking cessation was more common among 
cancer survivors. Women with breast cancer answering the questionnaire more than 2.4 
years after diagnosis reported larger changes than those answering closer to diagnosis. 
Women diagnosed in stage 2 reported larger changes than women diagnosed in stage 1.  
 The comparison of dietary supplement use in the EPIC-study (n=36 034) revealed a 
clear North-South gradient, with almost ten times as many female users in Denmark as in 
Greece. The difference was even larger among men. Among Norwegian women 61.8% were 
users, compared to 67.0% among Danish women. Vitamins, minerals and combinations of 
them were most commonly taken in most countries. Cod liver oil and other oil-based 
supplements were common particularly in Norway and the UK.  
 Within the NOWAC-study we studied survival rates among those who developed solid 
cancers (n=2 997) in relation to use of cod liver oil and other dietary supplements before 
diagnosis. Whole-year users of cod liver oil and of other dietary supplements had increased 
survival, particularly lung cancer patients. Occasional use of other supplements also 
increased survival. The effect persisted even after adjustment for age, stage and smoking. 
Some of the effect might be a result of factors we could not adjust for. More research is 
needed in order to clarify the association.  
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Samandrag 
Avhandlinga dreiar seg om kosthald, kosttilskot og endringar i kosthald hos kvinner som har 
bryst- eller tarmkreft, jamført med kreftfrie kvinner i Kvinner og kreft-studien. I tillegg 
skildrar ho bruken av kosttilskot i European Prospecitve Investigation into Cancer and 
nutrition (EPIC). Til slutt blir assosiasjonen mellom bruk av tran og andre kosttilskot og 
overleving blant pasientar med kreftsvulstar frå Kvinner og kreft presentert. 
 Tverrsnittsstudien frå Kvinner og kreft viste at skilnadene i kosthaldet til kvinner 
som hadde brystkreft (n=666) og friske kvinner (n=54 314) ikkje var så store, men kvinner 
med brystkreft åt meir frukt og grønsaker. Det var særleg kvinner som hadde fylt ut 
spørjeskjemaet mindre enn fem år etter diagnosen som skilde seg frå friske kvinner. Det 
var også eit lågare nivå av fysisk aktivitet og fleire brukarar av kosttilskot blant desse 
kvinnene.  
 Oppfølgjingsstudien såg på om kosthaldet endra seg blant kvinner som fekk 
tarmkreft (n=130) eller brystkreft (n=563) jamført med kreftfrie kvinner (n=43 154). Dei 
som fekk brystkreft auka inntaket av frukt og grønsaker meir enn kreftfrie kvinner. 
Mjølkeforbruket var uendra blant dei som fekk tarmkreft, og minska blant kreftfrie 
kvinner. Auken i kroppsmasseindeks og alkoholforbruk var lik mellom gruppene. Røykeslutt 
var vanlegare blant dei som fekk kreft. Kvinner med brystkreft rapporterte større 
endringar om dei svara på siste spørjeskjema meir enn 2.4 år etter diagnosen enn før dette 
tidspunktet. Dei som fekk brystkreftdiagnosen i stadium 2 gjorde større endringar enn dei 
som fekk diagnosen i stadium 1.  
 Samanlikninga av kosttilskotsbruken i EPIC-studien (n=36 034) synte ein tydeleg 
nord-sør gradient, med nesten ti gonger så mange kvinnelege brukarar i Danmark som i 
Hellas. Blant menn var skilnaden endå større. Det var 61.8% brukarar blant norske kvinner, 
mot 67.0% blant danske kvinner. Vitaminar, mineral og preparat med både vitaminar og 
mineralar var vanlegast i dei fleste landa. Særleg i Noreg og Storbritannia var også tran og 
andre oljebaserte kosttilskot vanleg.  
Innanfor Kvinner og kreft-studien såg vi på overlevingsratane blant dei som fekk 
kreftsvulstar (n=2 997) i høve til om dei hadde teke tran eller andre kosttilskot før 
diagnosen. Dei som brukte tran eller andre tilskot heile året hadde noko auka overleving, 
særleg dei som fekk lungekreft. For andre kosttilskot såg ein også effekt av bruk 1-6 
gonger i veka. Effekten var der sjølv etter justering for alder, stadium og røyking. Noko av 
effekten kan ha kome av faktorar vi ikkje kunne justera for. Meir forsking trengst for å 
underbyggja resultata. 
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1 Introduction 
The total number of persons diagnosed with cancer and alive in the world in 2008 was 
estimated to be 25 million, and by 2030 it is expected to be 75 million persons alive with 
cancer within five years of diagnosis [1]. Cancer is today the most important cause of years 
of lives lost in Norway [2]. Even though many die from cancer in the end, in recent years 
treatment and prevention of cancer have improved, and with technology and programs for 
early detection of cancer more available, more and more people are living with cancer, 
and this number will continue to increase [3]. For example, the five-year survival rate for 
breast cancer was 85.6% among those diagnosed between 1997 and 2001 [4]. This is an 
increase of 35.2% compared with those diagnosed in 1957-61, the first period covered by 
the Cancer registry of Norway. For all cancer sites taken together, the chance of surviving 
cancer is now 53.8% higher for women than it was in the first period of the registry, and 
62.2% of those diagnosed with cancer live more than five years after their diagnosis [4].  
The most frequent cancers in women in Norway are breast cancer with 75.6 cases 
per 100 000 person-years, colorectal cancer (including cancers in rectosigmoid junction 
and anus) with 34.6 cases per 100 000 person-years and cancer in the lung and trachea 
with 23.0 cases per 100 000 person-years in the period 2003-2007 [5]. By the end of 2007, 
over 183 252 men and women who had ever been diagnosed with cancer were alive in 
Norway. Among them 33 889 had experienced breast cancer as their first primary cancer, 
24 937 colorectal cancer and 4 536 lung cancer [5]. 
In Europe it was estimated that 7 281 590 persons were living with a prevalent 
cancer within five years of diagnosis in 2002 [6]. Among women the most common incident 
cancers were those of the breast, colorectum and lung, among men the most common 
incident cancers were those of the lung, prostate and colorectum.  
 
1.1 Cancer survivors 
Cancer survivorship was first described as a concept in 1985, by Fitzhugh Mullan, a medical 
doctor diagnosed with cancer [7]. The National Cancer Institute in USA has adapted their 
definition from the National Coalition for Cancer Survivorship: “An individual is considered 
a cancer survivor from the time of the diagnosis, through the balance of his or her life. 
Family members, friends and caregivers are also impacted by the survivorship experience, 
and are therefore included in this definition” [8]. Including family, friends and caregivers 
in the definition is somewhat controversial, even though a cancer diagnosis will have an 
impact not only on the person who gets it, but also on persons in her/his surroundings. The 
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recently established “Journal of Cancer Survivorship” recognizes that cancer also affects 
family and caregivers, but chose not to include them in the definition used for the journal, 
in order to keep focus on the research on survivors, which still is an emerging field of 
research [9]. The term cancer survivor/cancer survivorship is not as much used in Europe 
and European literature as in the US. In this thesis, the term cancer survivor is confined to 
persons who have ever had a cancer diagnosis.  
 The new definition, labelling patients as cancer survivors from the date of 
diagnosis, as opposed to when they had been disease-free for five years, have had effect 
both on how the disease has been perceived and the treatment options given to patients 
[10]. Both technological and other developments have contributed to transforming cancer 
from almost incurable to a disease that some will be cured for, and many will live long 
with. Consequently, it is important to prompt patients and clinicians to think early about 
long-term effects. For example, the improved survival for childhood cancers has made 
treatment regimens that can preserve fertility an issue, and as cancer survivors are at 
increased risk of second cancers and other diseases, promoting healthy lifestyles in 
survivors has become a priority [11] (see 1.1.1 and 1.1.2).  
 Cancer survivorship encompass several phases and people with very differing needs, 
but at least three periods are often distinguished: the period after diagnosis, but before 
treatment, the treatment period, and the period after treatment [12]. The period after 
treatment will differ depending on whether the treatment was successful or unsuccessful, 
whether the patient develops a metastasis or a cancer at a different site or not. The 
definition of cancer survivorship research used by the US National Cancer Institute is 
presented in box 1.  
 
 
Box 1: Cancer survivorship research  
Cancer survivorship research encompasses the physical, psychosocial, and 
economic sequelae of cancer diagnosis and its treatment among both 
paediatric and adult survivors of cancer. It also includes within its domain, 
issues related to health care delivery, access, and follow up care, as they 
relate to survivors. Survivorship research focuses on the health and life of a 
person with a history of cancer beyond the acute diagnosis and treatment 
phase. It seeks to both prevent and control adverse cancer diagnosis and 
treatment-related outcomes such as late effects of treatment, second cancers, 
and poor quality of life, to provide a knowledge base regarding optimal follow-
up care and surveillance of cancers, and to optimize health after cancer 
treatment.  
   Office of Cancer Survivorship, National Cancer Institute [8] 6 
1.1.1 Health issues for cancer survivors 
Even when the cancer is cured, cancer survivors are facing a diversity of sequelae including 
physical and physiologic problems that may require medical treatment, as well as societal 
and interpersonal issues and fear of recurrence [3].   
The risk of developing second cancers in survivors are higher than the risk of 
developing primary cancers in the general population, and in the US cancer survivors 
represent 3.5% of the population, but account for about 16% of the incident cancers [13]. 
Cancer survivors are also at higher risk of other conditions such as cardiovascular disease, 
diabetes, and osteoporosis compared with age-matched controls [13-15]. US data show 
that cancer patients are significantly more likely to die from non-cancer causes than the 
general population [14]. This may result from side effects of the cancer treatment, genetic 
predisposition and that common lifestyle factors are parts of the causes for all these 
conditions. A problem with studies on treatment related late effects/long-term effects is 
that the results we get today originate from treatment regimens that may now be 
obsolete. Still, the information about adverse effects of older therapies can help improve 
the new therapies, and the design of surveillance programs.  
 In Norway, cancer survivorship research is rather limited. Much of the research on 
treatment effects has been done on testicular cancer survivors, e.g. [16]. A population 
based study showed that survivors of six different cancers diagnosed five years or more 
prior to the study reported poorer health than their age- and gender-matched controls did 
[17]. The survivors had used both general practitioners (70% vs. 66%) and the specialist 
health care system (43% vs. 28%) more often than the controls the last 12 months 
preceding the survey. In addition, the proportion of survivors on social welfare benefits 
was higher than in the controls (14% vs. 11%). Seventy percent of the survivors reported at 
least one health complaint, compared to 66% of the controls. There were no differences in 
smoking, obesity and inactivity [17].  
 
1.1.2 Dietary issues for cancer survivors 
Getting adequate amounts of foods and nutrients could be a challenge for cancer survivors. 
Nutrients could be supplied from foods, but also from dietary supplements. The dietary 
issues for cancer survivors differ according to the phase of survivorship. For some cancer 
sites (e.g. lung cancer) and for cancers detected in an advanced stage the general 
condition of the patient is often quite poor [18,19]. This means that the cancer patient 
may enter the treatment with compromised nutritional status. A study from the UK found 
that 28% of the lung cancer patients had poor nutritional status defined as low pre-
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operative albumin, recent history of weight loss or low BMI [18]. Nutritional status had no 
impact on hospital mortality, and cardiac or respiratory complications. However, 
nutritional status was a predictor for long term survival, independently of tumour 
extension and staging.  
 Depending on the treatment chosen for each patient, the treatment itself can 
affect the nutrition status and appetite. Examples of nutrition-related side-effects of 
treatment are anorexia, early satiety, changes in taste and smell, disturbances of the 
gastrointestinal tract, nausea, vomiting, weight change, cachexia, loss of lean mass and 
sarcopenia [19]. If any of these symptoms occur, normal food choices and eating patterns 
may need to be temporarily adjusted to optimize intake and meet nutritional needs. A 
Norwegian study of dietary intake and nutritional indicators during radiotherapy for rectal 
cancer showed a transient reduction in energy intake and nutritional indicators, but no 
change in nutritional quality [20]. When active cancer treatment is ongoing, the overall 
goals for nutritional care for survivors should be to prevent or reverse nutritional 
deficiencies, to preserve lean mass, to minimize nutrition-related side-effects, and to 
maximize quality of life [19]. For those at risk of unintentional weight-loss, preventing 
weight loss and maintaining energy balance is an additional goal. Some people chose not to 
utilize conventional therapy, or use complementary therapies such as radical diets, energy 
restriction, orthomolecular nutrition or specific diet to cure the disease [12].  
For most survivors, cancer treatment occupies a limited time period, and the diet 
after treatment is of more concern. Some forms of treatment damage the metabolic 
function; this particularly concerns patients where parts of the digestive tract (mouth, 
oesophagus, stomach, small intestine or colon) have been removed or irradiated so that 
absorption is decreased. The specific challenges of this group will not be dealt with in this 
thesis.  
 
1.1.2.1  Prevalence of dietary and lifestyle factors in cancer survivors 
Studies relating food and nutrition to cancer have focused mostly on aetiology and primary 
prevention [21]. Studies of populations after cancer diagnosis have focused largely on 
therapeutics or prognostic factors, and much less on lifestyle factors. To the extent that 
lifestyle factors have been studied in relation to prognosis, it has been the impact on 
quality of life, not survival or recurrence that has dominated the literature. The diet one 
observes among cancer survivors might be a result of pre-diagnosis dietary habits that have 
been continued, or also of dietary changes triggered by the diagnosis. Diet and other 
lifestyle habits are known to influence cancer risk [12], so unless there has been change 
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from pre-diagnosis habits, survivors, at least from some cancers, could be expected to 
behave less in agreement with recommendations than the cancer-free population.  
Comparisons of lifestyle factors in cancer survivors with age-matched controls or 
scientific recommendations have often yielded discouraging results [22-27]. Only a 
minority meet the five-a-day recommendation for fruit and vegetables in survivor cohorts 
[23,24,26], and studies comparing survivors to non-cancer controls found no differences in 
fruit and vegetable intake [25,27]. Considering fat intake, the results have varied: one 
survivor study showed a high prevalence of low-fat diets (69%) [26], another found fat 
intakes similar to the general population [24], while a study with a non-cancer control 
group showed a low prevalence of low-fat diets in both groups [25]. Fibre intake was low 
[24], and not different from the control group [25]. One study reported high prevalence of 
overweight, and higher weight gain in younger breast cancer survivors than older [24]. 
Similar prevalence of overweight and risky drinking behaviours between survivors and 
controls has been reported [25,27]. Similar alcohol consumption was also reported from 
another study with non-cancer controls [22]. Except for one Australian study, all studies 
were done in US populations, so how these results reflect the Norwegian or European 
situation is not known. 
 Although one study reported that most survivors engaged routinely in physical 
activity [26], only a minority met the goal of 150 minutes of moderate to strenuous or 60 
minutes of strenuous activity per week [22,23,25]. Two studies reported that the levels of 
physical activity were similar between survivors and controls [25,27], while another 
reported that survivors were 9% more likely to meet physical activity recommendations 
[22]. Few differences in smoking habits have been found, except a tendency of more 
smoking among younger survivors than controls [22,25]. An Australian study found that 
survivors, particularly those under 40 years were significantly more likely to be current 
smokers [27]. In the studies of survivors only, the prevalence of smoking were ten percent 
or less [23,24,26]. 
 The differences in results between studies could be real, but also an effect of 
methodological differences (only one study used a full dietary registration [24]) or 
differences in study population characteristics and cancer sites studied.  
 Patients with pre-invasive lesions, e.g. adenomas, are an intermediary group 
between cancer-free and cancer survivors. A prospective Norwegian study found weak 
inverse associations between adenoma growth and intake of fruit and berries, 




1.1.2.2  Dietary and lifestyle change in cancer survivors 
A number of reports have suggested that cancer survivors adopt diet and lifestyle changes 
in hope of achieving improved health, often without advice from health professionals [29-
38]. Most frequently the changes take a healthy direction, cutting down on fat 
consumption and increasing the intake of fruits and vegetables [39]. However, most of the 
studies on cancer survivors have been done in US populations, have a retrospective or 
cross-sectional design, have not used validated methods for measuring diet or have not had 
a comparison group of cancer-free persons.  
How dietary change (and other lifestyle change) in cancer patients is associated 
with time is not well described, neither whether it is persistent, nor if it differs according 
to time since diagnosis [3,39,40]. Variations in change according to stage of disease are 
seldom studied [3]. However, as described in 1.1.2.1, health behaviours do not seem to 
differ much between cancer survivors and healthy populations or non-cancer controls, at 
least not in a cross-sectional perspective [22,24,25].  
Much of the knowledge about cancer survivors and diet/lifestyle has come from 
studies of breast cancer survivors and studies of childhood cancer survivors. Some recent 
studies of colorectal cancer survivors show results similar to those found among breast 
cancer survivors [33,37,41,42]. In a Norwegian intervention study patients with colorectal 
polyps were given either a mixture of vitamins and minerals or a placebo [43]. One year 
after the intervention no major dietary changes which could be associated with a changed 
susceptibility for malignancy were found.  
This study and others were reviewed in the 2007 WCRF/AICR expert report [12,44]. 
Meta-analyses of trials on dietary modifications and supplements used by cancer patients 
and patients with preinvasive lesions were performed, and 25 trials with cancer patients 
and 34 with patients with preinvasive lesions were found. Trial quality was generally low, 
and there was no clear evidence of benefit or harm with any of the exposures, neither on 
all-cause mortality nor on cancer mortality, disease-free survival, cancer recurrence, 
second primary cancer, recurrence of a preinvasive lesion or progression to cancer. 
Additionally, two large, multicentre, randomized trials of dietary modification in breast 
cancer survivors published after the first literature review [45,46] (see below) were taken 
into account by the expert panel. The final report stated that no conclusions could be 
derived from the results of studies on ‘healthy diets’ for cancer survivors [12]. The panel’s 
advice for cancer survivors was therefore to follow the dietary recommendations for 
cancer prevention.  
Two large US prospective intervention studies have focussed on dietary change in 
breast cancer survivors. The Women’s Intervention Nutrition Study (WINS, n=975 in 
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intervention, n=1462 in control group) tested the effects of a low-fat diet on breast cancer 
recurrence risk [45]. Interim results showed a lower risk of recurrence (HR 0.76, 95% CI 
0.60-0.98, p-value 0.08), but the intervention group had more extensive surgical 
procedures and lost weight, which might account for the effect. Women with negative 
hormone receptor status tumours had a more beneficial effect [45]. The Women’s Healthy 
Eating and Lifestyle (WHEL, n=1537 in intervention, n=1551 in control group) study tested 
the effect of a diet high in fruits and vegetables and low in fat on breast cancer recurrence 
[46]. The intervention did not affect prognosis or mortality, neither did it lead to changes 
in body weight between the intervention group and the control group [46]. Several 
explanations for the differences in results between these studies have been discussed, 
including different timing of study entry relative to diagnosis, differences in fat reduction, 
differences in intervention maintenance, differences in weight reduction and difference in 
treatments between study groups [47,48]. The definitive results from the WINS study were 
expected in mid-2008 [48], but have not been published by the end of March 2009.  
The WHEL study included women up to 4 years after diagnosis, mean time between 
diagnosis and randomization was approximately 2 years. The participants reported making 
dietary changes after diagnosis, before randomization, and particularly changes in fat 
consumption were more likely with longer time since diagnosis [49]. If there is a critical 
time window shortly after diagnosis or completion of treatment, it might have been 
missed. Earlier interventions as in the WINS study, or pre-diagnosis diet might be more 
important for recurrence. Results from the control arm of the WHEL study suggest that 
women with higher baseline plasma carotenoid levels had a significantly reduced risk for 
breast cancer recurrence (HR 0.57, 95% CI 0.37-0.89 for highest compared to lowest 
quartile of carotenoids) [50]. However, quartile CIs overlapped, so threshold or dose-
response patterns could not be addressed. Since carotenoids are considered biomarkers for 
fruit and vegetable intake, this provides some support for a greater likelihood of 
recurrence-free survival in breast cancer patients who have had higher intakes of fruits 
and vegetables. In another study from the WHEL control arm, the combination of being 
physically active and eating more than five servings of fruits and vegetables a day at 
baseline almost halved the mortality (HR 0.56, 95% CI 0.31-0.98, p-value 0.04) compared 
to having low physical activity and eating less than five servings of fruits and vegetables 
[51]. This effect was seen both in obese and non-obese women. Given these conflicting 
results, the WRCF/AICR statement – that no conclusions can be drawn seems prudent.  
However, these large studies have, if nothing else provided evidence that dietary 
changes are feasible [52], and even if the results might not directly affect recurrence 
rates, the risk for other adverse health effects might have decreased. Some see the cancer 
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diagnosis as a “teachable moment”, a point in time where the motivation for making 
healthy changes to diet and lifestyle is strong, and an occasion for health care providers to 
engage not only in curative treatment, but also long-term health promotion [39].  
 
1.2 Dietary supplement use  
Dietary supplements are alternative sources of nutrients. Despite this they are not always 
queried in dietary surveys, so nutrient intakes may be underestimated. There is no 
commonly agreed definition for dietary supplements, neither for research, surveillance or 
regulatory purposes [53]. Sometimes dietary supplements are reported with medications, 
and sometimes they are reported as complementary and alternative medicine (CAM), 
particularly if taken in large doses. This is one of the reasons why questions and definitions 
vary so much between studies. The focus of this thesis is dietary data, not CAM 
information, still CAM data are used to enrich the background data when no other data 
have been found.  
Dietary supplement use is increasing [54], and although Norwegian prospective or 
repeated studies are lacking, consumption data show that households were spending more 
than five times more on vitamins, minerals, herbs and other dietary supplements in 2006 
compared to in 1988 [55]. Studies show that around 35% of the female adult population 
take cod liver oil [56-59], and 40-60% use other dietary supplements [56,60]. Cod liver oil 
use has a long tradition in Norway, and the high content of vitamin D has been important 
in preventing osteomalacia and rickets during the winter season when there are periods 
with low or no cutaneous production of vitamin D [56,61,62]. It is also an important source 
of n-3 fatty acids [63]. 
The SENECA study of elderly persons compared dietary supplement use in 18 towns 
in 12 European countries, and is one of few comparative studies in Europe [64,65]. This 
study showed large geographical differences in dietary supplement use, with higher 
frequency of use in Northern countries. Norwegian participants reported high frequency of 
use, 40-50% of the participants took supplements in the 1988/89 survey [65]. Compared to 
nutrient intake data, the supplement use did not seem to be motivated by low nutrient 
intakes or poor diet quality [65]. Both at the follow-ups in 1993 and in 1999 23% of the 
subjects took dietary supplements [64]. Norway did not participate in the follow-up 
studies. Since dietary supplement use is increasing, these data are now rather old, the 
questions posed were not very elaborative, the local study samples small and not 
representative, and the study only included elderly persons (80 years and older at 
enrolment), more comparative studies of dietary supplement use in Europe are warranted. 
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A study from the US suggested that 73% of the adult population had taken dietary 
supplements the previous year [66], other studies have found lower prevalences, but notes 
methodological differences [67].  
 Comparing supplement use across studies is difficult due to differences in methods 
and definitions [53]. What is defined and perceived as supplements may differ between 
studies and between populations. Likewise, the time frame for supplement use may vary, 
e.g. the last month or the last year. Also, the level of detail in the supplement information 
varies, e.g. whether fixed or open questions are used, and whether information on 
contents and dosage is collected (cfr. section 3.3). This means that it is difficult to 
compare the level of dietary supplement use in Norway with other countries. Some 
countries or studies have developed dietary supplement databases [68], and in the US a 
database of dietary supplements based on analysed products is being developed [69]. No 
common European supplement database exists. In Norway a database is in progress [59]. 
 Some groups use supplements more often than others, most studies show that 
female gender, older age, higher socioeconomic status and lower BMI [56,70-76] predict 
supplement use. Several studies have also shown that supplement use is higher in various 
patient groups [77-80]. 
 
1.2.1 Prevalence of dietary supplement use in cancer survivors 
Many studies have measured dietary supplement use in cancer survivors, and particularly 
breast cancer survivors have been well studied [77]. A recent systematic review from the 
US suggests that supplement use is widespread in cancer patients and longer-term survivors 
[77]. In studies where different cancer sites were combined, 64-81% of survivors used any 
kind of vitamin or mineral supplement, and 26-77% used any kind of multivitamin, 
compared to the adult US population where ca 50% used dietary supplements and 33% used 
multivitamin/multimineral supplements. Between 14 and 32% of survivors started using 
supplements after diagnosis, and use differed with cancer site [77]. Dietary supplement 
use was most common in breast cancer survivors, and least in prostate cancer survivors, 
and use was most consistently associated with female gender and higher education.  
Patients often don’t inform their doctors about their supplement use [77,81]. Given 
the high prevalence of use, more studies are needed to explore the association between 
dietary supplement use and cancer treatment toxicity, recurrence, survival, and quality of 
life. For example, taking antioxidants, particularly in high doses is controversial, as there 
is concern that they might interfere with radio- or chemotherapy treatments, and thereby 
reduce survival [19,82]. Some therefore advice patients not to take supplements during 
treatment [82]. The WCRF/AICR recommendation is to try to meet nutritional needs 
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through diet alone [12]. The American Cancer Society suggests that during treatment, 
when it can be difficult to consume a normal diet, a standard multivitamin pill containing 
up to 100% of the Daily Value could be helpful in covering nutritional requirements [19]. 
More research is needed before evidence-based clinical guidelines for dietary supplement 
use among cancer patients and longer-term survivors can be developed [77]. 
 Not many comparative data exist on dietary supplement use among European 
cancer patients. A European survey found that among 956 patients from 14 countries 35.9% 
were using CAM, ranging from 14.8 to 73.1% [83]. Herbal medicine and vitamins/minerals 
were among the most frequently used therapies both after diagnosis and at the time of the 
study. Subjects reported that they had initiated CAM use after diagnosis, and herbal 
medicine use had tripled from before diagnosis. Unfortunately, no country specific 
estimates were given on types of CAM, and the study sample was neither random nor 
nationally representative, so these data should be interpreted with caution [83]. 
 In Norway, some smaller studies have described dietary supplement use in cancer 
patients, but with one exception [20] not in relation to dietary intake [84-86]. Among 
rectal cancer patients surveyed four times from start of therapy till one year after 
completion, 74% took supplements at some point, but most patients did not use 
supplements at all registrations [20]. Use was highest one year after completing therapy 
(71%), and several different types of supplements were taken. Another study surveyed 
patients (in or after active treatment) attending diagnose specific courses [85]. Among the 
patients, 56% were using “products from the health food market”, and 36% used such 
products in relation to their cancer. Younger patients used these products more often than 
older patients, but no gender differences were found. 
 Another Norwegian study showed that herbal use among cancer patients receiving 
palliative or curative chemotherapy treatment did not differ between groups (37% and 
38%, respectively) [84]. The study was followed up by an identification and exploration of 
herb-drug combinations used by cancer patients during chemotherapy [87]. For the 42 
patients that used herbs concurrently with chemotherapy, 136 different herb-
chemotherapeutic combinations were found. For 48% of the herbal remedies identified no 
data existed in the literature on possible interactions with chemotherapy. 
 In a national study comparing cancer patients with poor prognosis (<20% expected 
five-year survival) and better prognosis (40-60% expected five-year survival) and their use 
of CAM five years after diagnosis, 18.4% of the poor survival group had used dietary 
supplements in doses above recommended daily allowances, and 13.4% of the better 
prognosis group, the difference was not statistically significant [86]. Approximately 7% of 
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the patients in the two groups reported use of diet as treatment, meaning that they had 
made radical changes to their diet.  
 
1.2.2 Dietary supplement use, cancer incidence, survival and mortality 
Several studies have been performed in order to assess if dietary supplements could reduce 
cancer risk in the general population or in high risk groups [88]. For well-nourished 
populations, not much evidence for beneficial effects exists [12,88]. There is convincing 
evidence that high-dose beta-carotene supplements are a cause of lung cancer in smokers 
[12]. Recent randomized studies showing no effect of vitamin D and calcium 
supplementation on colorectal cancer [89], and no effect of selenium and vitamin E 
supplementation on prostate cancer [90] do not support some of the other conclusions 
from the WCRF/AICR report. 
Even though the trials with dietary supplements for prevention of recurrence and 
death in cancer survivors reviewed for the WCRF/AICR report generally had more 
participants and better quality than the dietary intervention trials in cancer survivors, no 
conclusions about beneficial effects could be drawn [12]. More recently published 
randomized controlled trials have added to the picture with findings of no effect of alpha-
tocopherol and beta-carotene supplementation on upper aerodigestive tract cancer 
mortality [91], and similarly for vitamins C and E and beta-carotene on cancer mortality 
[92]. Observational studies have found a possibility for increased risk of fatal prostate 
cancers in men taking high levels of multivitamins along with other supplements [93]. A 
Swedish study found no association between use of any dietary supplement or of 
multivitamins, vitamin C, vitamin E or fish oil specifically and all-cause mortality, cancer 
or cardiovascular mortality [94]. However, this study noted increased risk of cancer 
mortality among current smokers using supplements. Similar results were found in the 
SENECA study, no associations for non-smokers, and increased mortality was observed for 
smokers using any supplements and vitamin B1 or vitamin B2 supplements.  
Few recent studies have looked at dietary supplement use and survival in cancer 
patients, but a study of nonvitamin, nonmineral supplement use found better survival rates 




The general aim of this thesis was to provide insight into the diet, dietary supplement use 
and dietary change in cancer survivors compared to a cancer-free control group. Further, 
to provide descriptive data on dietary supplement use in Europe, and to study the 
association between use of dietary supplements and survival.  
 
The specific aims were to: 
1. Cross-sectionally compare diet and lifestyle in breast cancer survivors and healthy 
women. 
2. Longitudinally describe and compare diet and lifestyle in breast cancer survivors, 
colorectal cancer survivors and cancer-free women. 
3. Describe the use of dietary supplements in ten European countries, and some 
health-related factors associated with use. 
4. Explore the association between use of cod liver oil, other dietary supplements and 
survival of cancer patients with solid tumours.  
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3 Material and methods 
This thesis utilizes data from two prospective cohort studies, the Norwegian Women and 
Cancer study (NOWAC) (papers 1, 2 and 4) and the calibration sub-cohort from the 
European Prospective Investigation into Cancer and nutrition (EPIC) (paper 3). The cohorts 
are linked, a sub-cohort of the NOWAC study constitutes the Norwegian EPIC study, and 
the Norwegian part of the EPIC calibration sub-cohort is randomly selected from the 
Norwegian EPIC study, see figures 3.1 and 3.2.  
 
The NOWAC study (n≈172 000) 
The Norwegian EPIC study (n=37 226) 
The calibration sub-cohort of the Norwegian 
EPIC study (n=1 798) 
 
Figure 3.1: Relationship between the NOWAC study and the Norwegian EPIC study. For 
clarity the sizes of the circles are not proportional to the sample sizes 
 
3.1 The Norwegian Women and Cancer study 
The Norwegian Women and Cancer study (NOWAC; Kvinner og kreft) is a national, 
population-based cohort study which enrolled the first participants in 1991 [96,97]. The 
primary aim was to investigate the relationship between oral contraceptive use and breast 
cancer. Due to study logistics, financial reasons and a wish to do methodological 
substudies, the first enrolment was divided in 24 mailings over seven years (figure 3.2). 
This thesis only uses data collected from participants included during the first enrolment 
wave. A second wave of enrolment of new participants started in 2003, and a new 
recruitment wave is expected to start in the autumn of 2009.  
The participants have answered one, two or three questionnaires, and some have 
participated in one [98] or four 24-hour dietary recalls (24-HDR) [99]. Participants who 
were born between 1943 and 1957 and agreed to be contacted again have been asked to 
donate at least one blood sample (figure 3.2).  
17 
Questionnaires collected in 1991-1995 only had a limited set of dietary questions, 
not comparable to those collected from 1996 and onwards. Therefore, the baseline data in 
this thesis are partly from the NOWAC baseline mailing (1996/97) and partly from the 
second mailing (1998-99) to those enrolled in 1991/92 (full circle in figure 3.2). Hereafter 
data collected in 1996-1999 are called thesis baseline in order to distinguish them from the 
NOWAC baseline data collected in 1991-99. Consequently, the follow-up data in this thesis 
are partly from the second mailing to those recruited in 1996/97 and partly from the third 
mailing to those recruited in 1991/92 (dashed circles in figure 3.2). Data collected in 2002-
05 are called thesis follow-up, and data collected from 1998 and onwards are called 
NOWAC follow-up. See appendix II for examples of questionnaires and appendix III for the 
translation of a questionnaire.  
 
3.1.1 Sampling, invitation and ethical issues  
The participants are selected randomly from the Central Person Registry kept by Statistics 
Norway, using the unique national identity number each inhabitant is assigned by law 
[100]. The selection is based on year of birth, and some series sampled participants from 
Northern Norway only. For confidentiality, the national identity numbers are replaced with 
serial numbers on the material sent to the participants, and in the files the researchers 
receive.  
The selected women receive a letter of invitation together with the questionnaire, 
a booklet covering most brands of oral contraceptives and postmenopausal hormone 
therapy sold in Norway, and a pre-paid return envelope. The invitation letter explains the 
aim of the study, that participation is voluntary and that the participants can withdraw 
from the study at any time, without giving any reason (see appendix I). One or two written 
reminders have been sent. The response rate for the first NOWAC mailing was 57% [97]. 
The process is similar for the NOWAC follow-up mailings; Statistics Norway is given the list 
of participants who have consented to be contacted again, and sends questionnaires to 
those alive and residing in Norway. The invitation letter explains why the women are 
contacted again, that new and updated information is needed, but that participation still 
is voluntary. The response rate to the second NOWAC mailing was 81% corrected for death 
and emigration [97]. 80.7% of the invited women who responded to the second mailing also 
responded to a third mailing (unpublished data). 
On all questionnaires the participants were asked to mark that they consent to 
participate, and the NOWAC study has got a legal exemption from confidentiality rules for 
medical registries. The study has been approved by the regional committee for medical 
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ethics, the National Data Inspectorate and the biobanks are managed after directions from 
the Norwegian Directorate for Health.  
 
3.1.1.1 Study samples 
Figure 3.2 (adapted from Lund [97]) gives an overview of the enrolment in the NOWAC-
study. Number of women recruited (NOWAC baseline, black boxes), completing second 
(striped boxes) and third (grey boxes) questionnaires, and number of blood samples are 
displayed, along with year of enrolment, age and length of questionnaire. For readability, 
some simplifications have been made regarding length of questionnaire: Series 11-16; 19-
24 had 2-8 pages. Series 25 and 27 had four pages; series 26, 28 and 29 had 8 pages. 
Further, series 29 was collected in 1999, and not in 1998 as depicted in the figure. 
As explained above, some of the participants (series 1-13 in figure 3.2) had only a 
limited set of dietary questions in their NOWAC baseline questionnaire, which could not be 
used for nutrient calculations. Most of these series were methodological studies testing 
various questionnaire lengths and other factors that could influence participation rates 
(series 4-8 and 11-16). To increase the sample size and statistical power, data from 
questionnaires collected in the same time period (1996-99), with similar content were 
pooled together (series 14-16, 19, 20, 22, 23, 26, 28 and 29) to form the thesis baseline 
(within the full circle in figure 3.2). The series in dashed circles (except 34), are the thesis 
follow-up series. The thesis follow-up series all had participants both from series with no 
or limited dietary questions in addition to those with comprehensive dietary questions. 
Only participants with comprehensive dietary registration at thesis baseline were included 
in the analyses. Figure 3.3 focuses exclusively on the series included in the thesis. 
A small sub-sample of women drawn from a young age-band (aged 40-44, series 21, 
n=586), was not included in paper 1, and therefore also not in paper 2 which is a follow-up 
study of paper 1, but contributed cases for paper 4.  
Series 28 and 29 constitute the Norwegian EPIC cohort, and the participants in the 
calibration study (paper 3) were drawn randomly from these series. The EPIC calibration 
study participants who also filled in the thesis follow-up questionnaire (series 39 and 42) 
and developed cancer after completing the thesis baseline questionnaire (series 28 and 29) 
were eligible for all four papers.  
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 Figure 3.3 Timeline for included series and methodological studies 
1996  1997  1998  1999  2000  2001 
Series 
14-161,19-20   21-232   26, 28, 29   Calibration study3 
 
 
1Series 14 and 15 had 6 pages (all other questionnaires had 8 pages) 
2Series 21 only included in paper 4 
3Randomized selection from series 28 and 29, only included in paper 3 
 
 
3.1.2 Dietary assessment and validation 
Diet was assessed using a semi-quantitative food frequency questionnaire (FFQ). The 
dietary questionnaire was developed and validated against serum phospholipids by 
Hjartåker [101]. It was constructed to measure habitual diet the preceding year, with 
special focus on fish and marine products, but did not aim to capture the entire diet. The 
questionnaire is continuously being improved, and as new hypotheses have been 
developed, the food supply changed and need for clarifications have been seen, questions 
have been included, omitted or changed. To a large extent, this has been guided by 
various methodological studies. Table 3.1 shows the number of frequency questions in the 
different series.  
A new validation, a comparison with repeated 24-hour recalls was performed in 
2003 [99]. A test-retest study has also been performed [102] along with a study of how to 




Series   
32,33     39  42 
2002  2003  2004  2005  2006  2007 
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Table 3.1 Number of frequency questions in the different series 
Series Number of frequency questions1
14, 15, 16 82 
19, 20, 21 74 
22, 23, 26 73 
28, 29 85 
32, 33 90 
39, 42 113 
1Frequencies of food, non-alcoholic and alcoholic drinks and dietary supplements 
 
 The results of these methodological studies were that the intake of marine 
products, particularly fatty fish and cod liver oil correlated well with the intake measured 
as content in phospholipids in serum [101]. The questionnaire’s ability to rank participants 
was good for foods eaten frequently, and macronutrients expressed as percentage of 
energy intake [99]. For more infrequently eaten foods and some micronutrients weaker 
ranking abilities were seen. The reproducibility of the NOWAC FFQ is within the range 
reported for similar instruments, but may still attenuate estimates of disease risk [102]. As 
for missing values, a frequently encountered problem with FFQs, the methodological study 
in our material showed that null value imputation may lead to underestimation and 
misclassification of dietary intake, therefore testing of newer imputation methods was 
encouraged [103].  
 
3.1.3 Dietary calculations 
The dietary calculations were performed by a statistical program for SAS version 9.1 (SAS 
Institute Inc., Cary, NC, USA) developed at the Institute of Community Medicine, University 
of Tromsø for the NOWAC study [104]. The original program is constantly updated to 
reflect changes in the FFQ, changes in the food composition table and more effective 
programming. One notable difference is that the current version of the program uses 
edible portions directly instead of linking to the edible portions values in the food 
composition database for quantity calculations. 
 Through several steps the program transforms the frequency responses into 
frequencies per day, transforms portion responses into multiples of household measures or 
natural units when relevant, and takes seasonality into account. Some generic foods are 
split into more specific foods e.g. the question about apples/pears is split into 80% apples 
and 20% pears. The percentages are based on the 24-HDR data, sales data and common 
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sense. Then portion sizes and food composition database codes are assigned in order to 
link with the nutrient contents of the foods. Portion weights are largely adopted from a 
Norwegian table for household measures and weights for foods [105]. Some of the foods 
are summed up to get e.g. total amounts of fruits and vegetables consumed. 
A dataset is created for quantities eaten (in grams per day), and finally the nutrient 
contents of all the foods are summed up and a dataset with nutrients intakes per day (in g, 
mg, µg, kJ or other, as appropriate) is constructed. Throughout the program several logical 
checks are applied to make sure that the calculations and linkages are correct. Some 
special programming is applied to certain foods, e.g. fat spread on bread where the 
participants can tick more than one type, and the quantity is a combined measure of how 
many slices of bread/crisp bread they eat and how thick a layer of fat they normally 
spread on.  
For the thesis baseline calculations the 2001-version of the Norwegian Food 
Composition Database was used [106], while for the thesis follow-up calculations the 2006-
version was used [107]. This was done in order to ensure that the most up-to-date values 
available were used, but simultaneously avoiding using new values on old food data, foods 
which composition might have changed. An example of a food which composition often 
changes is margarine; both the fat sources (mainly vegetable oils) and the processing 
methods (influencing e.g. content of trans-fatty acids) have changed over the last years. In 
general the values from the food composition database have been used unchanged in the 
thesis. However, the composition of cod liver oil has changed twice over the period these 
data were collected, so when cod liver oil has been included in the calculations, the food 
composition database has been updated locally to include values reflecting the 
composition at the time of data collection.  
 
3.1.4 Non-dietary variables  
The NOWAC-questionnaires contain questions on a wide range of non-dietary variables. For 
this thesis the following self-reported variables were used: physical activity (scale 1-10), 
weight, height, smoking (never, former, current), menopausal status (pre, post), number 
of persons in household, number of children, mother with breast cancer, use of 
postmenopausal hormone therapy (current, former, never), education (years), household 
income, region of residence, income, self-reported health and diet’s importance for 
health. BMI was calculated as weight (in kilos) divided by the square of the height (in 
meters). In addition age at first birth and prevalence of certain diseases were tested as 
possible confounders. Prevalent diseases were also used as exclusion criteria (see 3.1.6). 
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3.1.5 Identification of cancer, vital status and emigration 
The Central Person Registry keeps record of vital status and emigration [100]. At given 
intervals a request is sent to Statistics Norway for an update of the vital status of the 
participants, and to confirm that they are still residing in Norway. By using the national 
identity numbers, Statistics Norway also links with the Cancer Registry of Norway in order 
to obtain information about cancer diagnoses [4]. The information is returned to the 
NOWAC researchers using the serial number, not the national identity number.  
 
3.1.6 Exclusion criteria 
An overview of the exclusion criteria is given in figure 3.4. In papers 1 and 2 BMI was used 
as an adjustment variable, and participants with missing values on height or weight were 
excluded. In paper 1 physical activity was also an adjustment variable, and participants 
with missing values were excluded. Between the work on paper 1 and paper 2, a validation 
study of the physical activity scale against a combined heart-rate and accelerometer 
method was performed. Preliminary results suggested that the validity of the scale was 
relatively limited (unpublished data). In addition, the physical activity scale is one of the 
questions with the highest percentage of missing values in the questionnaire, and 
exclusions of those with missing values on physical activity would limit the sample size. We 
therefore decided not to use physical activity as an adjustment variable in the main 
analyses in paper 2, but rather performed a separate analysis with physical activity as an 
adjustment variable to check if it affected the estimates.  
 Also the exclusion criteria for implausible energy intakes differed between paper 1 
and 2. In paper 1 the same criteria as was applied in the first food related papers from the 
cohort was chosen [104], while for paper 2 a more elaborate exclusion taking into account 
the relationship between energy intake and basal metabolic rate for the individual 
participant was chosen [108]. This criteria had been used in more recent NOWAC papers 
[109], and was also a response to a reviewer comment.  
In paper 1 participants reporting high blood pressure, myocardial infarction, heart 
failure, stroke or diabetes were excluded. This was done because they were older and 
differed in energy intakes, physical activity and BMI compared to other participants. It was 
also assumed that these participants might have received individual dietary advice for 
their conditions, and it was interesting to investigate dietary choices after cancer diagnosis 
compared to dietary choices in the healthy population, which presumably has not received 
individual dietary advice. These exclusion criteria were not used for paper 2. High blood 
pressure, stroke and heart failure did not show good reproducibility when data from the 
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two questionnaires were compared (unpublished results). Also, age at diagnosis had a lot 
of missing, making it difficult to distinguish those who got these conditions before 
answering the thesis baseline questionnaire from those who got the conditions after 
answering the thesis baseline questionnaire. Therefore, it was decided to compare persons 
who got cancer with all cancer-free persons, including those who suffered from various 
other conditions. 
Prevalent cancer cases were included in paper 1 and excluded from paper 2 and 4. 
Paper 4 concerns cancer patients, and all participants who were free from solid tumours 
until 01.01.07 were excluded. Participants with missing information on cancer stage, 
smoking, cod liver oil or other dietary supplements were also excluded. Finally, those who 
were diagnosed upon death did not contribute person-time to the analyses and were 




series 14-16, 19, 20, 22, 
23, 26, 28, 29 (n=67 932) 
Questionnaire 1996-99, series 14-16, 19, 20, 22, 23, 
26, 28, 29 (n=67 932), and questionnaire 2002-05, 
series 32-33, 39, 42 (n=63 184) 
26 
missing values for weight 
missing values for height 
low/high energy intake 
missing values for physical activity 
missing values for weight, any 
questionnaire 
missing values for height, any 
questionnaire 
low/high energy intake, any 
questionnaire 
self-reported high blood 
pressure, myocardial infarction, 
heart failure, stroke or diabetes 
was not invited/did not answer 
follow-up questionnaire 
prevalent cancer(s) (before baseline 
questionnaire), or second cancer in survivor prevalent cancer not in breast 
answered follow-up questionnaire, but did 
not have a comprehensive first diet 
questionnaire 
breast cancer diagnosis <1 
year before questionnaire 
Included in paper 2 (n= 43 847) Included in paper 1 (n=54 980) 
Questionnaire 1996-99, series 14-16, 19, 20, 22, 
23, 26, 28, 29 plus series 21 (n=68 518) 
Questionnaire 1998-99, 
series 28, 29 (n=37 226) 
not selected/did not 
participate in 24-HDR 
no first primary cancer diagnosis 
missing values for smoking 
technical problems with 24-
HDR 
missing value for stage 
diagnosed upon death 
missing information on cod 
liver oil or dietary 
supplement use age not between 35 and 70 
(not relevant for 
Norwegian participants) 
Included in paper 3 (n=1 798) Included in paper 4 (n=2 997) 
Figure 3.4 Comparison of inclusions and exclusions in the papers. Arrows pointing 
to the right signify exclusions 
3.2 The European Prospective Investigation into Cancer and 
Nutrition 
The European Prospective Investigation into Cancer and Nutrition (EPIC) started in 1992 
and is a prospective multi-centre cohort study with 23 centres in 10 countries; Norway, 
Sweden, Denmark, The Netherlands, the United Kingdom, Germany, France, Spain, Italy 
and Greece [110]. The overall aim of the study is to investigate the relationship between 
diet and cancer. The large variation in cancer rates and dietary habits in the countries 
included in the study together with its large size help overcome many methodological 
problems with earlier studies. The EPIC study has evolved to study other diseases as well, 
and the size now allows for analyses of interactions between nutritional, genetic, 
hormonal and lifestyle factors.  
More than half a million participants are included in the cohort (366 521 women and 
153 457 men), most of them aged 35-70 years at recruitment [111]. The majority of the 
sub-cohorts were recruited from the general population residing in a given geographic 
area, with some exceptions. The French cohort consists of members of a health insurance 
program for school workers, half of the Oxford cohort in UK consists of vegans, vegetarians 
and other “health-conscious” persons, some of the Spanish and Italian cohorts consist of 
blood donors and their spouses, and the Utrecht (the Netherlands) and Florence (Italy) 
cohorts consist of women participating in mammography screening programs [110]. The 
French, Norwegian, Utrecht and Florence cohorts only recruited women.  
 
3.2.1 Ethical issues 
All participants consented to be included in the study, and the studies were approved by 
the ethical committees at the participating institutions and at the International Agency for 
Research on Cancer which coordinated the study [110]. 
 
3.2.2 Dietary assessment 
The baseline dietary assessment was performed with country-specific dietary assessment 
methods [112-115]. In most countries self-administered food frequency questionnaires of 
varying length were used, but some combined two methods [110]. In UK a semi-
quantitative FFQ and a 7-day record was used, and in Malmø a short non-quantitative FFQ 
with a 14-day record of hot meals was developed. In some of the Southern European 
centres the questionnaires were administered by interviewers. Data from the baseline 
dietary assessment have not been used in this thesis, and will not be discussed further.  
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 Since the dietary assessment methods differed between countries, a second, 
common dietary assessment was carried out in a sub-sample of the cohort in order to 
adjust for differences due to assessment methods rather than real intake [113]. The 
calibration sub-cohort consisted of between 5 to 12% of the population in each national 
cohort, except in UK where a sample size of 1 117 (≈1.5%) was chosen to provide 
population-level calibration. The second dietary assessment method was single 24-HDR, 
and a computerized 24-HDR software, EPIC-Soft, was developed to standardize dietary 
intake reporting across study sites, and to increase the likelihood that the measurement 
errors would be of a similar magnitude and nature in all study centres [116,117]. The EPIC-
Soft program had country-specific food lists and portion sizes, but information was 
collected in the same structured manner. A picture book(let) was used to aid in food 
quantification. Interviews were performed face-to-face at the study centres, except in 
Norway where telephone-interviews were used [98]. A comparison showed that telephone 
vs. face-to-face interview design did not influence recalled diet [98]. Food intakes from 
the 24-HDR have been reported elsewhere [118]. 
At the end of the interview a question about dietary supplements was asked: “Did 
you take any vitamins…?” The question was rather open, and only specified vitamins, but 
the country-specific supplement lists specified products beyond vitamins such as garlic and 
fish oil. A question about the physical state of each supplement was asked (e.g. liquid, 
tablet or injection), and the intake was quantified. The set of questions was repeated until 
all supplements taken were documented, and there was no upper limit on the number of 
supplements one participant could report, and products not included in the pre-specified 
lists could be added.  
 
3.2.3 Non-dietary variables, exclusions and participation rates 
Information about age, whether the participant followed a special diet, and whether the 
recalled day was a special day with regard to diet was collected during the 24-HDR, and 
was complete for all participants. Self-reported health was taken from the baseline 
assessment. As it was not among the core questions, it was not available from all centres. 
Prevalent cancer status was taken from the last cancer up-date before the 24-HDR. Some 
countries had prevalent cancer as an exclusion criterion, and prevalent cancer cases from 
these countries were therefore not included in the analysis on cancer status and 
supplement use. Information about cancer is obtained in different way in different sub-
cohorts, most use cancer registries, some use a combination of methods including health 
insurance records, cancer and pathology registries and active follow-up of participants or 
next-of-kin [110].  
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 Approximately 1% of the interviews performed were excluded, mainly due to 
technical problems locally, although some interviews were also excluded e.g. because the 
participants’ baseline data were incomplete [113]. The age ranges of the participants in 
the EPIC baseline study differed between sub-cohorts. Consequently, the age ranges in the 
calibration study also differed between sub-cohorts, but most participants were between 
35 and 74 years old, and those outside this age range were excluded from the analyses in 
paper 3. In addition, some participants (<1% of the final sample) were added to the 
calibration study, these were involved in other EPIC cross-sectional or validation studies 
and most of them were sampled from the calibration sub-populations [113]. The 
participation rates in the local centres varied from 46.5% to 92.5%, but except in Greece 
and the UK the all countries had participation rates above 60%. In Norway 61% of the 
approached women participated [113].  
 
3.3 Dietary supplements  
There is no commonly agreed definition of dietary supplements [53,119]. The meaning of 
the word may differ both between countries, within countries and over time. In paper 3 it 
was decided to use the EU regulatory definition as guiding definition, despite that this 
definition was adopted long after the data collection [120]. The question asked to the 
participants in the EPIC calibration study only specified vitamins, but the pre-specified 
supplement lists show that there must have been a broader, but maybe not very clear, 
definition as basis for the assessment. Papers from the baseline studies in several of the 
EPIC centres showed that supplement use was more than just vitamins e.g. [56,71,72,121]. 
This prior knowledge also helped deciding on a supplement classification [122], which 
mainly took the main ingredient(s) into account. For EPIC, it was not considered feasible to 
construct a dietary supplements database long after the actual consumption had taken 
place, and consequently no attempt to quantify the nutrient intakes from the supplements 
were made.  
The questions on dietary supplements asked in the NOWAC study has changed over 
time. In general, separate questions have been asked about cod liver oil, other fish oils 
and other dietary supplements (see annex II for examples of all the supplement questions). 
In some series cod liver oil and fish oil could be reported by a closed list of brand names 
(plus an option for “other”). In other series no brand name information was asked, only 
frequencies and in yet other series an open question was asked.  
 For other supplements only a frequency question and a question on brand name(s) 
were asked in some series (14-16, 19-21, 32-33), whereas in other series (22, 23, 26, 28, 
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29, 39 and 42) there was a conditional yes/no question before the frequency question. In 
some series (22, 23, 26, 28, 29) an example (vitamins, minerals) was used, in most series 
not.  
 
3.4 Cancer survivors 
Research on diet and cancer survivors is a relatively new discipline [3,10], and not much 
has been done in Norway [123]. The NOWAC study was not originally set up to study cancer 
survivors, so some methodological challenges arise. Ideally all survivors should have been 
sampled at a given, restricted time since diagnosis, preferably at diagnosis or e.g. after 
completed treatment [21]. This could have been done in a nested case-control study. Such 
a study is actually going on in the cohort; breast biopsies and supplementary blood samples 
are collected at cancer diagnosis, and age-matched cancer-free controls from the cohort 
are asked to donate blood [97]. However, in order not to burden the participants they are 
not asked to fill in the NOWAC questionnaire, just a short questionnaire on factors that 
might affect blood levels.  
 Variables related to treatment would also have been relevant to include in the 
analyses for paper 1, 2 and 4. Information on whether the cancer survivors were in active 
treatment or not when completing the questionnaire, and which type(s) of treatment they 
have been given could have informed the analyses. Some of the colorectal cancer survivors 
in paper 2 have probably had surgical treatment where parts of the gut have been 
removed, and this could affect their diet and nutrient absorption [124]. A national clinical 
registry for colorectal cancer has only recently been established [5], and does not cover 
the majority of our cases [5].  
  
3.5 Statistical analyses 
All analyses were performed using SAS release 9.1 (SAS Institute Inc., Cary, NC, USA).  
In papers 1 and 2 analyses of variance (ANOVA) were used to describe difference 
between breast cancer survivors and healthy women. This was done with the general linear 
models procedure in SAS. Multiple adjusted analyses were performed; hence type III least 
square mean estimates (mutually adjusted) were used. Post-hoc Bonferroni tests were 
used to determine which of the groups differed when significant differences were found in 
the anova analyses. Pairwise comparisons and stratified analyses were performed in order 
to further describe the differences and similarities in diet and lifestyle. Due to the large 
number of analyses the level of significance was set to p< 0.01. 
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Paper 3 will appear in a supplement issue on nutrient intakes in the EPIC calibration 
study, and a guideline for some common statistical analyses for all papers in that issue has 
been developed [125]. This guided the analyses, but some adaptations were made. Dietary 
supplement use was uncommon in some countries, and in order to increase the precision in 
the estimates it was decided to present data on gender and country level, not centre level 
as recommended in the guidelines. Adjusted mean percentages and standard errors at the 
country level were calculated using generalised linear models. The models were weighted 
for sampling differences in seasons and weekdays vs. long weekend at the centre level. 
The overall estimates were adjusted for age as a continuous variable, while the age-
specific estimates were stratified by 10-year age classes. Since there were few users 
and/or participants in some strata (particularly for men), the age-adjusted overall 
estimates were outside the range of the age-stratified estimates in some of the countries. 
This was because of the low precision in some of the estimates, and not because of real 
statistical differences. Analyses including only supplement users were based on crude data, 
as weighting among users would have removed the effect of seasonal and weekday 
variation in supplement use. Overall gender differences were tested in anova analyses, and 
age differences by centre and gender were tested in a regression model with age in 10-
year age groups as the predictor variable. Stratified analyses were performed for diet and 
health-related variables. P-values less than 0.05 were considered significant.  
In paper 4 the Cox proportional hazards model was used to calculate hazard ratios 
for mortality with corresponding 95% confidence intervals. Assumptions for the Cox 
proportional hazards model were tested and met. Time since diagnosis was used as the 
primary time-variable. Kaplan-Meier plots were constructed to describe the survival 
function. Survival differences between groups were assessed for statistical significance by 
the log-rank test. Differences between categories of cod liver oil and other supplement use 
were tested in analyses of covariance and Cochran-Mantel-Haenszel’s test adjusted for age 
at diagnosis. The level of significance was set to p< 0.05. The associations between cancer 
survival and cod liver oil and other dietary supplements use respectively were first 
examined in age-adjusted analyses. A set of potential confounders were tested individually 
in a model with age and supplement use, and whenever a significant change in risk by 
supplement use was observed, the variable was included in the multivariate models. If the 
estimate for supplement use in the multivariate adjusted model changed 5% or more when 
a confounder was included, it was kept in the model. Interaction between smoking and 
dietary supplement use was tested by including an interaction term in the models for total 
cancer.  
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4 Results – summary of papers 
Paper 1  
Diet among breast cancer survivors and healthy women. The Norwegian Women and 
Cancer Study 
 
The paper describes diet and lifestyle of breast cancer survivors and healthy women in a 
cross-sectional subset of the NOWAC study, and explores differences by time since 
diagnosis, by comparing short-term (five years or less) and long-term (more than five 
years) survivors.  
Among women aged 41-70 years who answered a questionnaire with dietary 
information in 1996-99, the Cancer Registry of Norway identified 314 short-term survivors 
with 1-5 years since diagnosis and 352 long-term survivors with more than 5 years since 
diagnosis. These women were compared with 54314 women free of cancer, diabetes, 
myocardial infarction, stroke, high blood pressure and heart failure. 
Overall there were few differences in the diet of the three groups. Short-term 
survivors ate more fruits (217 vs. 181 g) and vegetables (143 vs. 124 g) than healthy women 
(p<0.001), and consumed more of nutrients associated with this food group (fibre, mono- 
and disaccharides, folate, vitamin C and potassium). The percentage of dietary supplement 
users was higher (72% vs. 61%, p=0.003) and the level of physical activity was lower among 
short-term survivors than among healthy women (5.2 vs. 5.5, p=0.01). The long-term 
survivors did not differ from any of the other groups. In conclusion: Diet and lifestyle was 
generally similar between breast cancer survivors and healthy women, especially more 
than five years after diagnosis.  
 
Paper 2 
Dietary change among breast and colorectal cancer survivors, and cancer-free women 
in the Norwegian Women and Cancer cohort study 
 
The objective of this study was to investigate diet before and after diagnosis of breast and 
colorectal cancer compared with diet in cancer-free women in the NOWAC study.  
The paper reports dietary changes from a data collection in 1996-99 to another in 
2002-05. 43847 cancer-free women aged 41-70 years answered the baseline questionnaire 
and follow-up questionnaire on diet and lifestyle. Of these, 130 women developed 
colorectal cancer and 563 breast cancer between questionnaires. Dietary change in the 
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three groups was compared, and for breast cancer a comparison was made according to 
stage and time since diagnosis.   
Breast cancer survivors increased fruit and vegetable consumption with 81 g 
compared to 42 g in colorectal cancer survivors and 50 g in cancer-free women. Milk 
consumption was stable in colorectal cancer survivors, and decreased in cancer-free 
women. Significantly more cancer survivors quit smoking. There were no differences in 
change of alcohol consumption or BMI between the groups. In breast cancer survivors, most 
changes occurred more than 2.4 years after diagnosis, and stage II survivors made larger 
changes than stage I survivors. 
In conclusion: cancer survivors seemed to follow general dietary and lifestyle 
trends, and did not modify well-established cancer risk factors as alcohol and high body 
mass more than cancer-free women did. 
 
Paper 3  
Use of dietary supplements in the European Prospective Investigation into Cancer and 
Nutrition calibration study  
 
The aim of this study was to describe the use of dietary supplements in subsamples of 
participants from the 10 countries in the European Prospective Investigation into Cancer 
and Nutrition.  
Specific questions on dietary supplement use were asked as part of single 24-HDRs 
performed on 36 034 men and women aged 35-74 years from 1995 to 2000.  
Between countries the mean percentage of dietary supplement use varied almost 
10-fold among women and even more among men. There was a clear north-south gradient 
in use, with higher consumption in the northern countries. The lowest crude mean 
percentage of use was found in Greece (2.0% among men, 6.7% among women), and the 
highest in Denmark (51.0% among men, 65.8% among women). Use was higher in women 
than in men. In Norway 61% of the participants reported dietary supplement use. Vitamins, 
minerals or combinations of them were the predominant types of supplements reported, 
but there were striking differences between countries. Dietary supplement use seemed to 
be more common in persons with prevalent cancer than in cancer-free persons, but 
samples were small.  
This study indicates that there are wide variations in supplement use in Europe, 
which may affect individual and population nutrient intakes. The results underline the 
need to monitor consumption of dietary supplements in Europe, as well as to evaluate the 
risks and benefits. 
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Paper 4  
Cod liver oil, other dietary supplements and survival among cancer patients with solid 
tumours  
 
Survival of cancer patients with solid tumours in the NOWAC study was explored in relation 
to supplement use before diagnosis. We performed Cox proportional hazards analyses, 
adjusting for age at diagnosis, smoking and stage.  
Cod liver oil was the most frequently used dietary supplement, followed by 
multivitamins and –minerals. Before diagnosis, 46.4% of the patients were cod liver oil 
users, and 57.1% used other dietary supplements. Whole year daily use of cod-liver oil was 
associated with lower risk of death in patients with solid tumours (RR 0.77, 95% CI 0.61-
0.97) and in lung cancer patients (RR 0.56, 95% CI 0.34-0.92). Also daily and occasional use 
of other dietary supplements decreased the risk of death among lung cancer patients (RR 
0.70, 95% CI 0.49-0.99 and 0.55, 95% CI 0.31-0.97).  
More research is needed in order to clarify the association; meanwhile adjustment 
for dietary supplement use should be performed in survival analyses of lung cancer 
patients.   
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5 Discussion 
Issues related to study design and validity will be discussed before the results.  
 
5.1 Study designs 
Different study designs might help illustrate a scientific issue in different ways. This 
section discusses and compares the study designs used in this thesis and highlights some of 
their strengths and limitations. Some alternative approaches are also discussed. 
 
5.1.1 Cross-sectional versus prospective studies 
In paper 1 a cross-sectional design was used, while in paper 2 a prospective study design 
was used. Cross-sectional studies provide information on exposure (prevalent cancer) and 
outcome (diet) without information on the temporal relationship between them, since all 
information is collected at one point of time. Therefore, cross-sectional studies cannot 
inform us about causal relationships, but can suggest presence or absence of associations 
between exposure and outcome [126]. Paper 1 indicated that there were differences in the 
diet of breast cancer survivors and cancer-free women, and that it was relevant to pursue 
the analyses in a more elaborate design. In the prospective design the time-effect 
relationship is established, as the exposure (incident cancer) is measured before the 
outcome (change in diet from pre- to post-diagnosis) [127]. However, chance, confounding 
and bias might still distort the associations.  
 One of the aims of this thesis was to describe dietary change in cancer survivors 
compared to cancer-free women. For this the prospective design is superior, however, 
most studies to date have used a cross-sectional or retrospective design [39]. 
 
5.1.2 Transformed cohort studies versus dedicated survivor cohorts 
Doing survivor research in a traditional cohort, a transformed cohort design, has some 
limitations. One alternative to studying cancer survivors in a cohort designed for other 
purposes would be a cohort of survivors only, a dedicated survivor cohort. This design has 
some possible benefits [21]. First, all participants could be enrolled at a uniform time 
(period) since diagnosis. Second, baseline diet is measured after diagnosis, and third, 
follow-up could be done at specific intervals after diagnosis, not at given calendar times. 
This means that presumed critical periods can be more uniformly studied, but it requires 
rapid case ascertainment in order to enrol potential participants soon after diagnosis [21]. 
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Updates via cancer registries typically take months or years, and may therefore not be 
rapid enough. 
Many of the above mentioned benefits can be compensated for within a 
transformed cohort. Regular repeated measurements can limit time between diagnosis and 
enrolment, and can also help cover critical periods [21]. Actually, since update of cancer 
status takes time, unless one is in a clinical setting, a transformed cohort study might 
include survivors sooner after diagnosis than a dedicated survivor cohort. In paper 2 we 
took advantage of the repeated measurements in the cohort. Mean time since diagnosis 
was 2.4 years for breast cancer survivors. In Norway cancer incidence and survival is 
released annually from the Cancer Registry, with a lag of approximately 13-25 months 
between diagnosis and publication of numbers. Consequently, enrolment at a uniform time 
close to date of diagnosis would have been impossible unless special arrangements had 
been made with local hospitals. For breast cancer this might not be that critical, but for 
cancers with low survival rates, such as lung cancer, the lag between diagnosis and 
enrolment introduces substantial survival bias (see 5.2.1). Anyhow, for such cancers, the 
effect of post-diagnosis diet or changes in diet might be less important than the pre-
diagnosis diet. If post-diagnosis diet is of more concern, one can study prevalent cancer 
cases in the cohort, unless they were excluded from the study. In NOWAC, prevalent 
cancer is not an exclusion criterion, and paper 1 is an example of this kind of analysis. 
However, such an approach will most likely suffer from survival bias.  
Transformed cohorts are only an option for frequent cancers. For rarer cancers 
transformed case-control studies is a possibility. When converting case-control studies into 
survivors studies many of the same challenges as with transformed cohort studies exists, 
and rapid case ascertainment and periodic follow-up might help overcome some of them 
[21].  
Newly established survivor intervention studies have not always taken advantage of 
the possible design benefits mentioned above: The WHEL study enrolled women up to 4 
years after diagnosis [46], while the WINS study restricted enrolment to those 1 year or 
less after diagnosis [45]. In survivor cohorts enrolment have taken place e.g. within 2 
months [128], at 6 months [21], 4-12 months [129], approximately 9-15 months [21], 10-11 
months [40], and on average 2 years [24] after diagnosis. Follow-up is scheduled at uniform 
calendar times [21,24,129] or at given periods since diagnosis [21,40,128]. Most of these 
studies have chosen to include only early-stage survivors. As a result of these choices, 
many of the survivor studies are not more standardized than studies done within a 
traditional cohort design. 
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Dedicated survivor studies might be superior for some aspects of prognosis 
research, but it might not be the case for all aspects of cancer survivorship research. Many 
early studies of cancer survivors suggested that the practice of healthy lifestyle behaviours 
was higher in cancer survivors than in the general population, but these studies often 
lacked a comparison group from the general population [14]. When such comparative 
studies have been done, the differences between survivors and the general population has 
generally not been very large [22,25,27]. Paper 1 and 2 add to this picture.  
Since many of the cancer survivor studies have been cross-sectional, we cannot rule 
out that the survivors have made changes from unhealthier pre-diagnosis habits. It has 
been speculated that lifestyle changes could have been of a more temporary character, or 
that the results from previous studies might not generalize to all survivors [14]. Therefore, 
studies with population controls also have their place in the cancer survivorship field, and 
repeated measurements are helpful in elucidating the process of change, and potential 
relapse to old, pre-diagnosis habits. Traditional cohort studies might also provide 
information about the change process quicker, by taking advantage of the different length 
of period between diagnosis and follow-up questionnaires. This has been done both in 
paper 1 and 2, where dietary change in breast cancer survivors was evaluated according to 
time since diagnosis.  
Survivor cohorts will often have better data on medical and treatment issues, and 
have the possibility to use more targeted questions relating to the cancer experience. If 
they are conducted at major cancer centres, rather than by mail or telephone, they may 
not be representative of minorities, poor, rural and other hard-to-reach populations, 
particularly in countries where free health-care is not available for all [40]. Most 
survivorship studies concentrate on one single cancer site, usually the most frequent ones, 
making comparison between different cancers difficult [40]. Possibly the ideal design for 
studies of frequent cancers would be a nested case-control study in the cohort, with access 
to medical records for tumour and treatment specific information, extra questionnaires to 
the survivors related to their disease, but also with questionnaire(s) to cancer-free 
controls in order to keep the comparison with the general population. 
 
5.1.3 24-hour dietary recalls 
In the EPIC calibration study, dietary supplement use status was assigned based on the 
reported use on one single day. For data on the individual level, this is a highly unsatisfying 
study design. For individual data on nutrients the number of days needed per person for 
95% of observed values to lie within 80% of the true mean varies enormously from nutrient 
to nutrient, e.g. from 4 days for total fat (energy-adjusted) to 106 days for vitamin A 
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(energy-adjusted) [130]. However, the aim of the present study was not to give individual 
estimates, but to provide comparable country-specific estimates. Given the many problems 
with dietary supplement definitions, reference periods, duration and content (cfr. 3.3 and 
5.2.2.3) it is considered that a single 24-HDR is a sufficient design for reaching the aim of 
the study, and superior to using EPIC baseline data, mainly collected from various FFQs. 
Since the results were weighted for season and weekday vs. weekend interviews, potential 
differences in patterns of use between countries should not confound the results. 
  If information on the individual level is sought, more than one recall should be 
collected per participant. An American study found that in comparison with a brief 
questionnaire, three recalls could accurately and reproducibly capture data on supplement 
use for frequently consumed products, but might perform less well for products used less 
often or more intermittently [131].  
 
5.2. Validity 
A study is considered to be valid if the findings can be taken as being a reasonable 
representation of the true situation [127]. Three factors generally compromise the validity 
of study findings; selection bias, information bias and incorrect use of statistical methods 
including failure to take confounding factors into account [132]. The term internal validity 
refers to the ability to draw conclusions regarding the study population [132]. External 
validity refers to the potential to draw conclusions also for other populations [132]. A 
debate about validity of dietary assessment methods in general, and FFQs in particular has 
been going on for years (e.g. [133,134]). The discussion of the validity of the NOWAC FFQ 
will concentrate on this specific FFQ, and not the method in general.  
 
5.2.1 Selection bias 
Selection bias occurs when there is a systematic difference between the characteristics of 
the individuals selected for the study and the characteristics of those who were not [126]. 
The methodological studies done in NOWAC have shown that women not born in the Nordic 
countries had lower response rates, women living in Northern Norway had higher response 
rates, and that the response rate dropped with increasing age [96]. Linkages to the 
Norwegian fertility registry and the registry of education showed that the participants 
were younger, fewer were nulliparous or uniparous, but the proportion of women with 
three or more children were approximately the same as in the source population. 
Responders had a slightly higher age at first birth, and a higher percentage had more than 
12 years education compared with the source population.  
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No difference was found in the distribution of self-reported parity, ever use of oral 
contraceptives and years of education in non-responders (who participated in a non-
respondent study) and responders from the same series [96]. Reasons for non-participation 
were e.g. worries about confidentiality, lack of time or interest, and simply forgetting 
about it. Data from the Cancer Registry of Norway showed that cumulated incidence rates 
in the NOWAC study and in all Norwegian women of the same age were almost identical 
both for all cancer sites combined as well as for breast cancer [96]. Therefore, although 
only 57% of the invited women responded to the NOWAC baseline questionnaire and the 
participants were somewhat younger and better educated, the conclusion was that no 
major selection bias that would invalidate the calculation of population attributable risk 
was found [96].   
 The participation rate corrected for death and emigration at the first NOWAC 
follow-up questionnaire was 81%. Since there may be selection bias from baseline to 
follow-up, participants responding to the NOWAC follow-up questionnaire were compared 
with all women responding to the NOWAC baseline questionnaire regarding the information 
given at enrolment. Almost no differences were found in the comparison, but those who 
completed the follow-up questionnaire were slightly younger (46.4 vs. 45.9 years) and 
slightly better educated (11.8 vs. 12.0 years) [97]. This suggests that combining data from 
the NOWAC baseline questionnaire and the first NOWAC follow-up questionnaire to form 
the thesis baseline did not lead to selection bias.  
 Even though selection bias does not appear to be a problem in general, there might 
be selection bias among the cancer survivors. This bias could go both ways, cancer 
survivors could be ill/under treatment, and less able or interested in participating in 
anything reminding them of the disease. Or, cancer survivors could be more motivated to 
participate in a cancer study than cancer free-women. Corrected for death and 
emigration, participant rates in series 28 were 82.1% among cancer-free participants 
originally enrolled in series 1-5, and 82.6% among those who developed cancer. For thesis 
baseline compared to thesis follow-up the total participation rate was 76.4%, among 
cancer survivors it was 74.2%. There is therefore no reason to believe that there is more 
selection bias among cancer survivors than among other participants. It has been 
demonstrated that the response rate was higher when the study was called “Women and 
cancer” than “Oral contraceptives and cancer” or “Women, lifestyle and health” [135]. 
One selection bias is obviously present in our study, namely the survival bias. Both in 
papers 1 and 2 (and 3) the survivors included are healthier than the total sample of 
survivors, since survivors who died before receiving the questionnaire were not eligible. As 
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survival rates are lower for colorectal cancer than for breast cancer, this might have 
affected the survivor groups in paper 2 differently. 
 For the EPIC baseline study, selection bias is not possible to assess correctly. 
Although most of the sub-cohorts were representative for persons residing in specific area, 
this was not the case for all of them [110]. Some sub-cohorts sampled people engaging in 
health related practices e.g. mammography program participants, blood donors or so-
called “health conscious” people. It is likely that these participants are more health 
conscious than the average, and that there is a so called healthy volunteer bias in the 
cohort [132]. Some of the sub-cohorts could not enumerate the invited population, and 
had no possibility for calculating response rates and difficulties making comparisons with 
the source population [110]. At the country level between 54.2% and 91.6% of the subjects 
selected for 24-HDR, actually participated. A slight tendency of underrepresentation of 
current and former smokers, and persons with low education compared to in the baseline 
sample was seen, so selection bias cannot be ruled out, but it was concluded that the 
calibration sample is fairly representative of the baseline cohort [113]. 
 
5.2.2 Information bias 
Information bias arises when the study subjects consciously or unconsciously give incorrect 
information, or the wrong information is recorded by study personnel or instruments [132]. 
The food information might be biased, as the accuracy of filling in questionnaires varies. 
Recall bias occurs when reporting differs according to disease status. In paper 1, it is 
possible that the breast cancer survivors reported their diet more accurately than the 
healthy women. Similarly, at follow-up in paper 2 the survivors might have filled in the 
questionnaire more accurately than the cancer-free women, but at baseline no difference 
in accuracy of reporting is expected in a cohort study. In dichotomous variables, 
misclassification will lead to attenuation of risk, and give estimates closer to zero, but in 
non-dichotomous variables such as most food data, the effect of the measurement errors is  
more unpredictable, though if measurement error is non-differential, the result is usually 
attenuation of risk estimates [132].  
 
5.2.2.1 Cancer and vital status 
In 2007 a special issue on data quality in the Cancer Registry of Norway was published [4]. 
The percentage of cases verified based on death certificate only was low, about 0.9% 
overall. The proportion of cases registered with primary site unknown has been stable over 
the period 1971-2005, around 3% of the cases [4]. Only 13% of the lung cancer cases, 9% of 
the colon cancer cases and 0.5% of the breast cancer cases were diagnosed with unknown 
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stage. The estimated overall completeness for the period 2001-05 was 99.7% [4]. The case 
registration is considered to be highly valid, which means that exposure assessment in 
paper 1 and 2 (prevalent and incident cancer) is valid. 
 Death notification is mandatory and reports are sent at least quarterly to the 
Central Person Registry. The registry is virtually complete, and the vital status is assumed 
to be highly valid [100]. Therefore, outcome (vital status) in paper 4 is highly valid.  
 
5.2.2.2 Diet and dietary change 
The validity of the NOWAC FFQ has been studied both in relation to a biomarker [101] and 
an independent dietary assessment method, 24-hour dietary recalls [99]. Reproducibility 
over a three month-period has also been studied [102]. These studies showed that the 
validity and reproducibility of the NOWAC FFQ is within the same range as in similar 
studies. The 24-HDR validation study also evaluated FFQ data from 1998 with 24-HDR data 
from 2002-2003, and found largely the same results as for the FFQ data collected in 2003 
[99]. The questionnaire has good ranking abilities, especially for foods eaten frequently 
and for macronutrients. However, as with all dietary assessment methods, there are 
measurement errors, and caution must be taken in interpreting the results.  
The 24-HDR validation study showed that the validity of estimates of milk and milk 
products, coffee and alcoholic beverages is good, even though the latter two were 
underestimated in the FFQ [99]. For fruits and vegetables the validity was fair, both food 
groups were overestimated in the FFQ compared to the 24-HDR. Misclassification into 
extreme quintiles occurred only in 2 and 1% of the occasions. The effect on the results in 
this thesis is probably that the absolute values of the change in fruits and vegetables is 
overestimated, while for milk and milk products it is fairly correct, and for coffee and 
alcoholic beverages it is underestimated. The relative change (e.g. change as a percent of 
baseline intake) should not be much affected.  
The three-month reproducibility study showed good results for the above 
mentioned food groups (e.g. Spearman correlations coefficients above 0.7). Still, in a 
simple analysis of the association between alcohol intake and the risk of hypertension the 
risk estimates were attenuated compared to the estimates calculated from the calibrated 
alcohol value [102]. The situation in paper 2 is much more complex; there are both 
adjustment variables with measurement error (e.g. BMI and baseline diet) and exposure 
variables without measurement error (cancer diagnosis, age and type of questionnaire), 
and measurement error in the outcome variables (dietary change). Therefore, it is not 
straightforward to predict how calibration would have affected the results in this paper 
[136]. 
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 The reason for sending out repeated questionnaires to participants is to update 
exposure information (e.g. dietary intake). One seeks to find out if the participants 
continued, discontinued or modified their lifestyle practices. A certain degree of stability 
is expected, and a follow-up study can also be seen as a long-term reproducibility study. 
The observed change is a combination of measurement errors and actual change. Long-
term reproducibility studies with FFQs (e.g. five years) have found correlation coefficients 
ranging from 0.41-0.77 in foods [137] and 0.42-0.90 in nutrients [138]. These studies 
concluded that there was good agreement between the measurements.  
A Japanese study with a 33 item FFQ found lower correlations and concluded that 
there were considerable changes in food intake over five years [139]. In addition to the 
food questions on follow-up, there was a question on subjective change for each food (no 
change, increased or decreased consumption). Subjective difference and longitudinal 
difference calculated from the change scores of the frequencies were poorly related, the 
direction of the change was inconsistent for more than half of the items. This shows that 
subjective change information might be incorrect, and repeated measurements probably 
give more precise information. 
Given the changes made to the NOWAC questionnaire, both within the thesis 
baseline, within the thesis follow-up and between thesis baseline and follow-up, long-term 
absolute reproducibility for some foods and many nutrients would most likely be rather 
low. For nutrients and food groups it is still possible that the ranking of participants would 
be satisfactory. The aim of the thesis was not to study the general trends in dietary intake 
in Norway, but to compare changes in dietary intakes in cancer survivors and cancer free-
women. Therefore, unless there is an interaction between cancer status and type of 
questionnaire, the differences in change should not be affected by the changes in the 
questionnaires. However, such an interaction might actually exist, since there is an 
interaction between age and cancer, and mean age among participants from series 14-23 
was higher than among participants from series 26-29. Since age and type of questionnaire 
was adjusted for in the analyses both in paper 1 and 2, we assume that the effect on the 
results was minimal.  
 
5.2.2.3 Dietary supplements 
The dietary supplements questions in the NOWAC study have been changed several times, 
partly to increase the validity, e.g. remove obsolete brand name options for cod liver oil 
and other fish oils capsules, and to give more room for brand names for other dietary 
supplements. Lay-out changes have improved readability, which should decrease missing 
values, and in some series a conditional yes/no question on use has been used so that non-
42 
43 
users could skip irrelevant questions. Two conclusions can be drawn from the cod liver oil 
questions: first, the supplement market is very dynamic, and brand name information is 
quickly getting obsolete. Second, many participants have problems distinguishing between 
cod liver oil and other fish oils. With open questions both for cod liver oil and fish oil, 
there was a considerable element of misreporting, e.g. cod liver oil was reported as fish oil 
and vice versa (unpublished results from an independent series where brand names were 
coded).  
 Both the format and the wording of the questions on other dietary supplements 
have also changed. As can be seen from table 5.1, this affected the prevalence of use.   
 The changes made, both the inconsistent use of conditional questions, and the 
omission of examples of dietary supplements, probably harmed validity, as seen by the 
falling number of users between 1998/99 and 2004/05 (table 5.1). Given that the sales 
more than doubled in the period [55], change calculations would most probably not have 
been valid, and dietary supplements were therefore not included in paper 2. Even though 
there were some differences in the supplement questions at baseline, there is no reason to 
believe that this should affect the cases and cancer-free women differently, but it adds to 
the imprecision in the estimate of users. Participants with missing answers on all questions 
were classified as non-users. Those who reported name, or answered yes to the conditional 
question, but no frequency, were assigned missing values. Therefore the estimate of users 
is a conservative one, and most likely underestimated. The prevalence at thesis follow-up 
indicates that the underestimation is larger in series without conditional questions.  
A problem when comparing dietary supplement use between studies is how 
frequency and duration of use has been recorded [53]. In the EPIC calibration study dietary 
supplement user status was determined based on one single day. Even if this does not 
reflect habitual use, group level estimates are assumed to be valid. No information was 
collected on duration or frequency of use. In the NOWAC study the participants are asked 
to think about the last year when they fill in the questionnaire, but no specific questions 
on duration are asked [56]. The EPIC baseline cohort queried supplement use in different 
reference periods in different countries, e.g. least four weeks during the past year [72,75], 
at least three times a week [76], and at least once during the seven days recorded [140]. 
Consequently, even though the EPIC baseline information reflected use over a longer 
period than the 24-HDR, a comparison of dietary supplement use at baseline would have 
been difficult, not only due to different definitions, but also due to the different reference 
periods for supplement use.  
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Series at thesis 
follow-up (timing) 







1996     45-69 Frequency,




brand names  
41.5 
22,23      1997 45-69 Conditional, frequency,




brand names  
41.9 
26,28,29      1998-99 41-55 Conditional, frequency,




brand names  
35.6 
1Brand names were coded as 1 if reported, else missing in thesis baseline. Thesis follow-up was optically read, and open ended variables on brand-names 
were not coded. 
2Prevalence among all participants with valid answers. Users were defined as those reporting a frequency higher than once a month. If all questions on 
supplements were left open, or the answer to the conditional question was no, the participant was considered a non-user. If no frequency was given, but 
some other information suggesting use, the participant was considered as having missing data, and not included in the prevalence estimates. 
 
No validation has been done on the EPIC dietary supplements data, but a crude 
comparison with published results from the local study centres showed prevalences in the 
same range as the calibration study [56,76,140-142], except in Spain [143] where use 
tended to be lower, and Germany where use tended to be higher in the local studies 
[72,75]. 
 
5.2.3 Statistical validity including confounding factors 
Diet and several lifestyle factors are related [104], therefore adjustment for possible 
confounding effects are important in diet-cancer analyses. In order to include a large 
number of adjustment factors in the analyses, particularly categorical factors, a large 
sample size is needed, and all groups compared must be quite large, as the entire 
distribution of all adjustment factors should be represented for all subgroups. If some of 
the subgroups are too small, or if a value on one of the adjustment factors is not 
represented in one of the groups, the analyses break down. For this reason, it was a priori 
decided to limit the number of adjustment factors in papers 1 and 2, and not to check for 
interactions, as the cancer survivor groups were quite small, and the analyses would 
quickly have broken down. For coherence it was also decided to apply the same 
adjustment factors to all foods and nutrients even though it is possible that some of the 
factors were confounders for one nutrient but not for another.  
Both in the 24-HDR validation study and the reproducibility study it is suggested 
that the application of calibration methods or other correction methods could give more 
accurate dietary intake levels and disease risk estimates [99,102]. Since the work with this 
thesis has taken place in parallel with the validation and reproducibility studies, this has 
not been done for the papers included in this thesis.  
The guidelines for the statistical analyses for the forthcoming special issue on 
nutrient intakes in the EPIC calibration study were written by statisticians. The guidelines 
had to be adapted a bit for the dietary supplements analyses, and this was done in 
collaboration with the guideline authors. The standard analyses were tested and improved 
by colleagues who were writing other papers for the special issue, and the methods used 
are considered appropriate.  
For survival analyses the Cox proportional hazards model was used. The assumptions 
for the proportional hazards model were tested and fulfilled. In general the statistical 
methods used are considered adequate to answer the research questions.  
Only a limited set of confounders were tested for papers 1, 2 and 3. This means 
that some of the effects may be overestimated due to other confounding factors; an effect 
of a factor (or factors) associated both with the exposure and the outcome variables. 
However, in paper 4 a long list of possible confounding factors were systematically tested, 
and except age, stage and smoking none of them had effects on the estimates in 
multivariate models. If there is measurement error in the adjustment error, so that the 
adjustment is not complete, there could be residual confounding.  
 
5.2.4 External validity 
The NOWAC cohort is drawn from the general female population in Norway. The 
methodological studies done suggest that the external validity is good [96,97], and since 
participation rates were the same in cancer survivors as in the total sample, we assume 
that the results also apply for female Norwegian breast and colorectal cancer survivors.  
 
5.3 Data interpretation 
Even though differences and changes in smoking, physical activity and BMI also are 
reported in the papers, the focus of the discussion is the diet and dietary supplements.  
 
5.3.1 Diet in cancer survivors and cancer-free women 
The main result is that dietary changes in cancer survivors and cancer-free women go in 
the same, healthy direction, but the magnitude of the changes is larger in cancer 
survivors.  
 Unfortunately, in Norway no national diet survey has been performed since 1997, 
and therefore comparisons with food data collected on the individual level are difficult. 
However, compared with trends in food supply statistics and household budget surveys, the 
dietary changes observed in the present studies generally follow the same trends, despite 
changes in the FFQ [144]. Both fruit and berries consumption and vegetable consumption 
(excluding potatoes) increased with 15% from 1999-2007 according to household budget 
surveys [144]. Our observation period does not completely overlapping this period, we 
have only studied women, but followed the same individuals, and recorded foods as eaten, 
whether it was bought or otherwise acquired. The increase in consumption among cancer-
free women was 18.4% for fruits and 14.3% for vegetables. Breast cancer survivors 
increased their fruit consumption with 29.2% and their vegetable consumption with 25.0%, 
and stage II breast cancer survivors made larger changes than stage I survivors. Colorectal 
cancer survivors increased their fruit consumption with 11.7% and their vegetable 
consumption with 15.6%. In cancer-free women there was a decrease of 14.2% in potatoes 
consumption, not including chips and crisps, a decrease which is also found in household 
46 
budget surveys [144]. Norwegian authorities want to double the intake of fruit and 
vegetables in the coming years [144], and five-a-day campaigns have been going on in the 
period between the questionnaires.  
 Also for sugar consumption large changes have taken place over the last years, 
much due to the very high consumption of soft drinks containing sugar in Norway. The 
consumption of carbonated sugar sweetened soft drinks decreased with 17.8% in household 
budget surveys from 1998 to 2007, while artificially sweetened soft drinks almost doubled 
[144]. Data on these drinks are not complete in our study, and not quite comparable 
because fruit/berry syrups are reported together with the carbonated drinks, while they 
are reported with fruits in household budget surveys. For the subsample where we had 
data both at thesis baseline and follow-up a decrease was observed both for sugar-
sweetened (-47%) and artificially sweetened soft drinks (-19%). 
 Consumption of milk has decreased considerably, down 27.6% from 1998 to 2007, 
and there has been a shift towards lower fat content milk [144]. In our data we have seen 
a decrease in milk consumption of 25%, but also a decrease in cheese consumption, where 
official statistics show the opposite. In paper 2 the decrease was most pronounced for low-
fat milk (1.5%), but a new type of extra low fat milk (0.7%) was introduced between thesis 
baseline and follow-up and included in the questionnaires, so some of the decrease in low-
fat milk was actually a change into the lower fat variety.  
The decrease in coffee consumption observed in our data is not found in household 
budget surveys, but coffee is a typical item consumed out of home, and thereby not well 
estimated in such surveys [144]. Cancer survivors decreased consumption more than 
cancer-free women, and in a sub-group analysis breast cancer survivors with stage II 
disease decreased consumption more than both cancer-free women and stage I survivors. 
Coffee questions have been unchanged throughout the study.  
According to household budget surveys wine intake more than doubled from 1998-
2007. Our data only show an increase of 27%, but intake is underreported, and more so the 
more the participants consume [99]. It is therefore not unlikely that the increase in wine 
consumption, the major contributor to alcoholic intake in our study, is underestimated.  
 Stronger conclusions can be drawn for breast cancer survivors than colorectal 
cancer survivors, since the colorectal cancer survivor group was rather small. That breast 
cancer survivors had the largest increase in fruit and vegetables fits with one of the 
characteristics of this survivor group, namely that they have higher socio-economic status 
[145,146]. Socio-economic status was not part of the general adjustment model, but the 
main analyses in paper 2 were re-done with education included in the model. Associations 
remained the same, even though the estimates changed somewhat. Therefore, it is not 
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likely that socio-economic status explains much of the observed differences. There is no 
clear socio-economic gradient among colorectal cancer survivors [145]. The Bonferroni 
tests in paper 2 did not show significant different changes in food intake between breast 
cancer survivors and colorectal cancer survivors, all the differences were between the 
cancer-free group and one (or both) of the survivor groups. Therefore we cannot say that 
breast cancer survivors made other changes than colorectal cancer survivors, but due to 
the relatively small group of colorectal cancer survivors, we cannot rule it out either.  
 Few comparable data exist from Norwegian studies, and few European data on diet 
in cancer survivors are available, at least obtained by validated dietary assessment 
methods, and with population controls. Guren et. al. noted that among 14 rectal cancer 
survivors (out of the 19 still alive) one year after completion of chemotherapy, there were 
no significant differences in energy and macronutrient intake compared to before 
treatment started [20]. Comparisons with US studies must be done with caution, 
methodological differences disregarded, the background dietary habits are different and 
the serving sizes, e.g. for fruits and vegetables are not comparable. A review noted that 
30-60% of survivors stated consumption of a “healthier diet” after diagnosis, the majority 
reported reduced meat intake and increase in fruit and vegetables, but the authors 
cautioned that not all of these studies used standardized, validated instruments or 
subscales to ascertain dietary intake [39]. One study of breast cancer survivors found small 
but significant decreases in energy and macronutrient intake postdiagnosis, and self-
reported change in fruit, vegetable and fat intake accurately reflected change as 
measured by the FFQ [38]. Mean number of fruit and vegetable servings did not increase, 
but small increases were observed in a sub-group of participants with self-reported 
increase in fruits and vegetables, one quarter to one third of a serving of fruit or vegetable 
per day. A two-year follow-up study of colorectal cancer survivors in North Carolina found 
increases in fruits (non-significant) and vegetables (significant) among survivors, but not 
among controls, and the difference in change was not significant [37]. Alcohol intake 
decreased in both groups, significantly among survivors. Use of any kind of dietary 
supplements increased significantly in both groups, and for antioxidant combinations the 
increase was larger in controls than in survivors. In the EPIC calibration study cancer 
survivors seemed to have a higher mean frequency of supplement intake, but subgroups 
were small, so no strong conclusions can be made. It seems possible that at least for some 
items Norwegian breast and colorectal cancer survivors made larger changes to their diet 
than US survivors did.  
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 Stage II breast cancer survivors made larger changes than stage I survivors, 
suggesting that the extent of the change differ with the severity of the illness. Few studies 
have compared dietary change in survivors in different stages [3].  
We don’t know much about the persistence of the changes, and the results from 
paper 1 and 2 are somewhat conflicting. Paper 1 suggested that those with the shortest 
time since diagnosis had the healthiest diets, while in paper 2 larger healthy changes were 
observed among those with longer periods since diagnosis. The length of the periods since 
diagnosis were different in the two papers, and changes might have been temporary, so 
both results could be correct, but generally paper 2 has a more appropriate design. Also 
internationally data are lacking on persistence of changes, but one cross-sectional study 
from the US suggested no differences in health behaviours by time since diagnosis, 
however, there might be differences across cancer sites [22]. Baseline data from the WHEL 
study suggested that the participants had made dietary changes between baseline and 
randomization, and that the longer since diagnosis the more likely was it that the 
participants had made changes to their fat intake [49].  
The assumption when starting our studies was that the changes to a large extent 
were spontaneous changes in the sense that the access to dieticians and individual dietary 
advice is rather limited for Norwegian cancer patients, unless they are malnourished, or 
parts of the gastrointestinal tract have to be removed as part of the treatment. General 
dietary advice is flourishing from all kinds of sources, and dietary changes take place, but 
most likely without qualified help, so it is likely that an opportunity is missed for even 
more improvements, and more targeted improvements [39]. 
   
5.3.2 Other lifestyle factors 
When it comes to other lifestyle factors, the most striking difference between cancer 
survivors and cancer-free persons was in smoking cessation. A general decrease in smoking 
among women is also seen in representative national statistics [147]. Body mass index is 
increasing in Norway [148], so the increase seen in our data is not surprising. Physical 
activity did not change between baseline and follow-up. Due to methodological differences 
and lack of nationally representative data, it is difficult to compare these data to the 
general population.  
 
5.3.3 Dietary supplements  
There is no reason to doubt that there are large differences in dietary supplement use in 
Western Europe, despite some limitations both to the methodology and the 
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representativeness of the EPIC calibration study. The North-South gradient found is similar 
to the gradient found in the SENECA study [65], but the levels were generally somewhat 
higher in the EPIC calibration study. A larger concern is whether the data correctly reflect 
the situation today, as supplement consumption is continuing to increase [54,55]. This 
highlights the importance of carefully planning both data collection, data processing and 
analysis before a study starts, in order to provide relevant and reliable data rapidly after 
data collection. The main purpose of EPIC was not to provide consumption data, but the 
standardized design of the calibration study makes it a good source for comparable data. 
Given that there is a lack of data on supplement consumption in Europe, the EPIC data fill 
in some gaps in our knowledge, and suggests that collaborative studies with data from 
different European regions should take dietary supplement use into consideration if they 
aim to produce results on nutrient intakes.  
 Compared to women in the other EPIC countries, the mean frequency of 
consumption in Norway was high, only among Danish women were dietary supplements 
used more frequently. The mean frequency of use reported in the 24-HDR was 61.0%, in 
comparison 71.4% used either cod liver oil (liquid or capsules) or other fish oil capsules or 
other dietary supplements in the Norwegian EPIC baseline (FFQ series 28 and 29). In table 
5.1 the corresponding percentage is 52.5, but this only includes other dietary supplements, 
not cod liver oil (liquid or capsules) or other fish oils. Given the high number of users, it is 
possible that the low increase in users in table 5.1 (series 14-16, 19-20) is not so far from 
reality. Even if dietary supplement spendings are increasing [55], it might be that the 
majority of this increase comes from new user groups (e.g. men or children), or from 
higher costs per user, in addition to increased prices. For series 22-23, 26 and 28-29 there 
was a decrease in use at thesis follow-up. This could at least partly be explained by the 
omission of the example (vitamins, minerals) in the supplement question at follow-up. In 
paper 1 61% of the healthy women used supplements, this was the same as in the EPIC 
calibration study, which suggests that this is a fairly valid estimate. The data in table 5.1 
was calculated from all participants completing the different questionnaires; no exclusion 
criteria were applied, except that from the thesis follow-up series only participants 
belonging to the thesis baseline series were included. Definitions for user status and 
missing information were the same as in paper 4. These were somewhat stricter than those 
used in paper 1, and together this explains the differences between the estimates in table 
5.1 and those from paper 1.  
 Also interesting was the difference in supplement types used in the EPIC countries. 
Though vitamins and minerals were dominating in most countries, oil-based supplements 
(mainly cod liver oil and other fish oils) constituted a large part of the supplements 
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consumed in many countries, particularly in the North-West of Europe. In total, vitamins C, 
E and D were the most frequently consumed supplement ingredients, due to the popularity 
of vitamins, multivitamins and –minerals and oil-based supplements. The SENECA study 
noted that vitamin supplements were taken much more frequently than mineral 
supplements [65], but in that study vitamin E was consumed to a lesser extent than some 
of the other vitamins. The association between gender and supplement use differed 
between towns in SENECA, while in EPIC there were more female users in all countries 
except among the health conscious, where no difference was found. A number of 
participants ingested the same ingredient from two or more supplements, suggesting that 
overdosing and possibly side-effects might be an issue, particularly for the fat-soluble 
vitamins [66,149,150]. Since quantification of the nutrient contents was not possible, this 
could not be investigated further.  
A new version of EPIC-Soft is being developed, and will avoid some of the problems 
with the previous version. Although the suggestion is not to include a standard definition of 
dietary supplements in the interviews, because current definitions will be too complicated 
to be informative for the study subjects, it is proposed to use printed examples to help the 
respondents understand what is meant with dietary supplements [151]. It is also 
recommended that packaging material and strength information should be collected, in 
order to get more information about the specific supplements. For nutrient calculations 
the need for dietary supplement databases are recognized, but the quick turnover of 
composition of dietary supplements makes if difficult to keep databases up-to-date [151].  
 
5.3.3 Dietary supplement use and cancer survival 
Paper 4 showed that daily consumption of cod liver oil or dietary supplements improved 
survival of cancer patients with solid tumours, particularly those with lung cancer. Even 
when adjusting for stage the effect persisted. The effect did not seem to be strongly 
related to dose, since the most frequently used supplement was multivitamins and  
-minerals, which generally contains modest amounts of nutrients. Neither did it seem to be 
strongly related to a specific nutrient, since both cod liver oil and other dietary 
supplements had the same effect. A long list of potentially confounding factors were 
tested in order to try to explain the variation, but only age at diagnosis, stage and smoking 
showed significant effects. Therefore we think that this paper brings some further 
evidence that dietary factors play a role for lung cancer survival [18,152-155]. Our results 
are not unique, other observational studies have found effects of vitamin and mineral 
supplementation [156,157] on lung cancer survival. A randomized double-blind trial of lung 
cancer mortality found no effects of supplementation [158]. Several intervention studies of 
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supplements and lung cancer incidence have not had the anticipated effect, rather the 
contrary [159,160]. Both dosing, chemical form of the supplements and characteristics of 
the study samples could explain some of the differences in results between incidence 
studies and survival studies. In general, intervention studies have methodological strengths 
which suggest that our results should be interpreted with caution.  
 The public health message of this paper is difficult. Data were collected before 
diagnosis, and therefore it brings no clear message to cancer survivors. Currently there is 
no evidence for recommending dietary supplements to well-nourished persons for cancer 
prevention or survival. The absolutely best advice for anyone wanting to avoid lung cancer 
is to avoid or stop smoking.  
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6 Conclusions and future perspectives 
This thesis has demonstrated that both cancer survivors and cancer-free women seem to 
make dietary changes over a period of approximately six years. The direction of the 
dietary and lifestyle changes made by breast and colorectal cancer survivors was most 
often the same as the direction of changes in the cancer-free population, but the 
magnitude was greater. Most of the changes seemed to be in line with general health 
advice, e.g. increase in fruit and vegetables, but not always consistent with cancer 
preventive advice (e.g. stopped smoking, but increased BMI and alcohol intake).  
 Dietary supplement use varies enormously in Western Europe, and there is a very 
strong North-South gradient. Multi-centric studies using nutrient intake as the exposure 
should try to take this into account. Not only the prevalence of supplement use differed, 
also the types of supplements showed some variation across the EPIC countries. Updated 
information is necessary in order to better describe the supplement use of today. 
Information also from other European countries, particularly Eastern European countries is 
needed. It is important to come up with a consistent recommended set of questions on 
dietary supplements both for the NOWAC study and the EPIC study. These should ideally 
change as little as possible over time. A second dietary measurement in the EPIC cohort is 
being discussed, and if it takes place, it will be important to use more standardized 
questions in the entire study population, also if other methods than EPIC-Soft will be used 
for dietary assessment.  
 The NOWAC FFQ has been validated with repeated 24HDR, but the data on dietary 
supplements have not been analysed. Since the changes in questions on dietary 
supplements affected prevalence of use, a validity analysis could help decide on the best 
questions to use in the future. Data from other methodological studies of the FFQ, e.g. 
studies with biomarkers, could also be analysed with dietary supplement question 
validation in mind. A dietary supplements database is being developed in Norway, and 
even though our dose information is far from complete, a possibility is to try and link our 
supplements data to this database. Given the high prevalence of dietary supplement use in 
Norway, it is important to have valid and accurate data on use. Questions related to 
beneficial and adverse effects of supplement use should be addressed, both in cancer 
survivors and the general population.  
 Lung cancer patients who used supplements (including cod liver oil) before 
diagnosis had better survival. Although some of the effect could be explained by smoking 
and stage, a significant effect persisted after adjustment. Smoking is by far the most 
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important factor for lung cancer incidence, but our results add to the evidence that also 
some dietary factors affect lung cancer.  
 This thesis has presented the first comparative data of diet and dietary change in 
Norwegian breast and colorectal cancer survivors, and one of the first larger comparisons 
of dietary supplement use on the European level. Much can be done to pursue and improve 
these findings. To date the majority of studies on diet and cancer have been concerned 
with primary prevention. As the cancer survivor population increases, efforts should also 
be directed towards elucidating whether diet and other lifestyle factors might affect 
cancer recurrence and cancer death. Given that cancer survivors are at increased risk for 
other often nutrition-related diseases, giving room for dietary counselling in cancer 
treatment and follow-up should be considered. For the time being, the scientific basis for 
specific advice for cancer survivors is limited, and several questions should be addressed:  
• Have foods, nutrients, dietary patterns or nutritional status a role in cancer 
recurrence or survival of cancer patients? 
• If there is a role for some of these factors, can it be attributed to specific foods 
or nutrients? 
• If there is a role for some of these factors, does it vary by cancer site or stage 
of disease? 
• If there is a role for some of these factors, is it pre- or postdiagnosis diet that 
has the most influential role?  
 
• If there are specific foods or nutrients that positively influence the health of 
cancer survivors, will they have similar effects in supplemental forms as in 
foods? Could there be adverse effects with such supplements? 
• Does supplement use interfere with cancer treatment? 
• If there is a role for some of these factors, how can we best inform patients and 
treatment teams about them? Is there a specific timing or means of information 
sharing that is more effective than another? Who should be responsible for 
giving out such information? 
 
For some cancer sites such as breast cancer, the NOWAC cohort is large enough to help 
answer some of these questions. For rarer cancers, larger collaborative studies are 
required, e.g. on the Nordic level. This will require thorough planning, even if existing 
studies should be used. Another possibility is to initiate a survivor cohort. A larger study 
would provide better possibilities for analyses of changes according to time since 
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diagnosis, stage of the disease, and more cancer sites. Ultimately interventions studies are 
needed. 
  Cancer survivorship research aims to optimize health after cancer treatment and 
dietary advice to cancer survivors could be a part of this. It is important for patients, their 
caregivers and their treatment team members to be informed about dietary and lifestyle 
factors that could be continued or modified in order to improve prognosis, in addition to 
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Material and methods, p 1047: 
In the sentence: This paper reports cross-sectional data collected between 1996 and 1998. 
the end of the data collection period should be 1999.  
 
Table 2, p 1049:  
The row “Butter/margarine spread on sandwiches” should read “Butter spread on 
sandwiches”.  
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